All approved drugs in PDB

User may click on the last column (View Results) to get results from sub-structural similarity searches that match all SARS-related structures.

Ligand ID
(Go to PDB)
DrugBank ID
(Go to DrugBank)
Drug NameIndicationView Results
010DB06770(Benzyl alcohol) Ulesfia (benzyl alcohol) lotion is indicated for the topical treatment of head lice infestation in patients 6 months of age and older. Ulesfia Lotion does not have ovicidal activity. View
017DB01264(Darunavir) Darunavir, co-administered with ritonavir, and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (HIV) infection in antiretroviral treatment-experienced adult patients, such as those with HIV-1 strains resistant to more than one protease inhibitor. View
032DB08881(Vemurafenib) Vemurafenib is approved since 2011 for the treatment of metastatic melanoma with a mutation on BRAF in the valine located in the exon 15 at codon 600, this mutation is denominated as V600E.[A31270] The V600E mutation, a substitution of glutamic acid for valine, accounts for 54% of the cases of cutaneous melanoma.[A31271] View
06XDB00381(Amlodipine) For the treatment of hypertension and chronic stable angina. View
08DDB01015(Sulfamethoxazole) For the treatment bacterial infections causing bronchitis, prostatitis and urinary tract infections. View
08HDB00404(Alprazolam) For the management of anxiety disorder or the short-term relief of symptoms of anxiety and for the treatment of panic disorder, with or without agoraphobia. View
08JDB00683(Midazolam) The midazolam injection is indicated for preoperative sedation/anziolysis/amnesia. It is also an agent for sedation/anziolysis/amnesia prior to or during diagnostic, therapeutic, or endoscopic procedures. Midazolam can also be given intravenously for induction of general anaesthesia. View
08YDB01200(Bromocriptine) For the treatment of galactorrhea due to hyperprolactinemia, prolactin-dependent menstrual disorders and infertility, prolactin-secreting adenomas, prolactin-dependent male hypogonadism, as adjunct therapy to surgery or radiotherapy for acromegaly or as monotherapy is special cases, as monotherapy in early Parksinsonian Syndrome or as an adjunct with levodopa in advanced cases with motor complications. Bromocriptine has also been used off-label to treat restless legs syndrome and neuroleptic malignant syndrome. View
097DB00786(Marimastat) For the treatment of various cancers View
0HKDB01409(Tiotropium) Used in the management of chronic obstructive pulmonary disease (COPD). View
0LADB00821(Carprofen) For use as a pain reliever in the treatment of joint pain and post-surgical pain. View
0LIDB08901(Ponatinib) Ponatinib is indicated for the treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy. View
0RNDB09324(Sulbactam) Sulbactam is currently available in combination products with ampicillin. Within this formulation it is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below. View
0TXDB00608(Chloroquine) For the suppressive treatment and for acute attacks of malaria due to P. vivax, P.malariae, P. ovale, and susceptible strains of P. falciparum, Second-line agent in treatment of Rheumatoid Arthritis View
0U9DB01128(Bicalutamide) For treatment (together with surgery or LHRH analogue) of advanced prostatic cancer. View
0WMDB08916(Afatinib) Afatinib is a kinase inhibitor indicated as monotherapy [L2937] for the first-line [FDA Label] treatment of (a) Epidermal Growth Factor Receptor (EGFR) TKI (tyrosine kinase inhibitor)-naive adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumours have non-resistant EGFR mutations as detected by an FDA-approved test [FDA Label], and (b) adult patients with locally advanced or metastatic NSCLC of squamous histology progressing on or after platinum-based chemotherapy [FDA Label, L2937]. View
115DB01095(Fluvastatin) To be used as an adjunct to dietary therapy to prevent cardiovascular events. May be used as secondary prevention in patients with coronary heart disease (CHD) to reduce the risk of requiring coronary revascularization procedures, for reducing progression of coronary atherosclerosis in hypercholesterolemic patients with CHD, and for the treatment of primary hypercholesterolemia and mixed dyslidipidemia. View
117DB01076(Atorvastatin) May be used as primary prevention in individuals with multiple risk factors for coronary heart disease (CHD) and as secondary prevention in individuals with CHD to reduce the risk of myocardial infarction (MI), stroke, angina, and revascularization procedures. May be used to reduce the risk of cardiovascular events in patients with acute coronary syndrome (ACS). May be used in the treatment of primary hypercholesterolemia and mixed dyslipidemia, homozygous familial hypercholesterolemia, primary dysbetalipoproteinemia, and/or hypertriglyeridemia as an adjunct to dietary therapy to decrease serum total and low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (apoB), and triglyceride concentrations, while increasing high-density lipoprotein cholesterol (HDL-C) levels. View
142DB00190(Carbidopa) For treatment of the symptoms of idiopathic Parkinson's disease (paralysis agitans), post-encephalitic parkinsonism View
15MDB00905(Bimatoprost) For the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension who are intolerant of other intraocular pressure lowering medications or insufficiently responsive (failed to achieve target IOP determined after multiple measurements over time) to another intraocular pressure lowering medication. View
15UDB00278(Argatroban) Argatroban is indicated for prevention and treatment of thrombosis caused by heparin induced thrombocytopenia (HIT). It is also indicated for use in patients with, or at risk for, HIT who are undergoing percutaneous coronary intervention. View
198DB01128(Bicalutamide) For treatment (together with surgery or LHRH analogue) of advanced prostatic cancer. View
1E8DB09053(Ibrutinib) Ibrutinib acquired an accelerated approval for the treatment of mantle cell lymphoma who have received at least one prior therapy.[FDA label] Mantle cell lymphoma (MCL) is a B-cell non-Hodgkin lymphoma that develops in the outer edge of a lymph node. MCL is usually diagnosed at late stages and it is easily spread into bone marrow, spleen, liver and gastrointestinal tract.[L1929] View
1FLDB00861(Diflunisal) For symptomatic treatment of mild to moderate pain accompanied by inflammation (e.g. musculoskeletal trauma, post-dental extraction, post-episiotomy), osteoarthritis, and rheumatoid arthritis. View
1GNDB01296(Glucosamine) Glucosamine is usually used in the treatment of osteoarthritis, although its efficacy is still in question. View
1KXDB01048(Abacavir) For the treatment of HIV-1 infection, in combination with other antiretroviral agents. View
1LDDB01099(Flucytosine) For the treatment (in combination with amphotericin B) of serious infections caused by susceptible strains of Candida (septicemia, endocarditis and urinary system infections) and/or Cryptococcus (meningitis and pulmonary infections). View
1N1DB01254(Dasatinib) For the treatment of adults with chronic, accelerated, or myeloid or lymphoid blast phase chronic myeloid leukemia with resistance or intolerance to prior therapy. Also indicated for the treatment of adults with Philadelphia chromosome-positive acute lymphoblastic leukemia with resistance or intolerance to prior therapy. View
1PCDB03575(Phencyclidine) View
1PQDB01087(Primaquine) For the treatment of malaria. View
1UNDB00220(Nelfinavir) Used in combination with other antiviral drugs in the treatment of HIV in both adults and children. View
1WEDB00182(Amphetamine);DB01576(Dextroamphetamine) For treatment of Attention Deficit Disorder with Hyperactivity (ADDH), narcolepsy, and exogenous obesity as a short term (a few weeks) adjunct in a regimen of weight reduction based on caloric restriction for patients refractory to alternative therapy.;Used to treat attention deficit hyperactivity disorder (ADHD). View
1X9DB01034(Cerulenin) For use as a biochemical tool, Cerulenin is shown to cause dramatic weight loss in animals View
1YNDB01167(Itraconazole) For the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: pulmonary and extrapulmonary blastomycosis, histoplasmosis, aspergillosis, and onychomycosis. View
20JDB01119(Diazoxide) Used parentally to treat hypertensive emergencies. Also used to treat hypoglycemia secondary to insulinoma. View
210DB00282(Pamidronate) For the treatment of moderate or severe hypercalcemia associated with malignancy View
212DB00630(Alendronic acid) For the treatment and prevention of osteoporosis in women and Paget's disease of bone in both men and women. View
21BDB00540(Nortriptyline) Primarily indicated for the relief of symptoms of depression. View
225DB01023(Felodipine) For the treatment of mild to moderate essential hypertension. View
27RDB00963(Bromfenac) For the treatment of postoperative inflammation in patients who have undergone cataract extraction. View
29EDB00476(Duloxetine) For the acute and maintenance treatment of major depressive disorder (MDD), as well as acute management of generalized anxiety disorder. Also used for the management of neuropathic pain associated with diabetic peripheral neuropathy, and fibromyalgia. Has been used in the management of moderate to severe stress urinary incontinence (SUI) in women. View
29JDB06700(Desvenlafaxine) Desvenlafaxine is indicated for the treatment of major depressive disorder in adults. View
29QDB00579(Mazindol) Used in short-term (a few weeks) treatment of exogenous obesity in conjunction with a regimen of weight reduction based on caloric restriction, exercise, and behavior modification in patients with a body mass index of 30 kg of body weight per height in meters squared (kg/m<sup>2</sup>) or in patients with a body mass index of 27 kg/m<sup>2</sup> in the presence of risk factors such as hypertension, diabetes, or hyperlipidemia. View
29SDB06401(Bazedoxifene) Investigated for use/treatment in osteoporosis and menopause. View
2C0DB00181(Baclofen) For the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. View
2DIDB00900(Didanosine) For use, in combination with other antiretroviral agents, in the treatment of HIV-1 infection in adults. View
2FADB01073(Fludarabine) For the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen View
2GMDB00320(Dihydroergotamine) For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. View
2PMDB01075(Diphenhydramine) For the treatment of symptoms associated with Vertigo/Meniere's disease, nausea and vomiting, motion sickness and insect bite. View
2PPDB00313(Valproic Acid) For treatment and management of seizure disorders, mania, and prophylactic treatment of migraine headache. In epileptics, valproic acid is used to control absence seizures, tonic-clonic seizures (grand mal), complex partial seizures, and the seizures associated with Lennox-Gastaut syndrome. View
2TNDB00335(Atenolol) For the management of hypertention and long-term management of patients with angina pectoris View
2UODB06693(Mevastatin) Not used therapeutically due to its many side effects. View
308DB00915(Amantadine) For the chemoprophylaxis, prophylaxis, and treatment of signs and symptoms of infection caused by various strains of influenza A virus. Also for the treatment of parkinsonism and drug-induced extrapyramidal reactions. View
30BDB06290(Simeprevir) Indicated for the treatment of adults with chronic hepatitis C virus (HCV) infection: typically in combination with sofosbuvir in patients with HCV genotype 1 without cirrhosis or with compensated cirrhosis and in combination with peginterferon alfa (Peg-IFN-alfa) and ribavirin (RBV) in patients with HCV genotype 1 or 4 without cirrhosis or with compensated cirrhosis. View
30ZDB00179(Masoprocol) Used for the treatment of actinic keratoses (precancerous skin growths that can become malignant if left untreated). View
356DB08882(Linagliptin) Linagliptin is used for the management of type 2 diabetes mellitus. View
377DB01043(Memantine) For the treatment of moderate to severe dementia of the Alzheimer's type. View
37TDB01412(Theobromine) theobromine is used as a vasodilator, a diuretic, and heart stimulant. And similar to caffeine, it may be useful in management of fatigue and orthostatic hypotension. View
3CJDB00550(Propylthiouracil) Used to manage hyperthyroidism which is due to an overactive thyroid gland (Grave's disease). View
3QBDB01627(Lincomycin) Lincomycin is an antibiotic used in the treatment of staphylococcal, streptococcal, and <i>Bacteroides fragilis</i> infections. View
3TCDB00709(Lamivudine) For the treatment of HIV infection and chronic hepatitis B (HBV). View
3WFDB00977(Ethinyl Estradiol) For treatment of moderate to severe vasomotor symptoms associated with the menopause, female hypogonadism, prostatic carcinoma-palliative therapy of advanced disease, breast cancer, as an oral contraceptive, and as emergency contraceptive. View
40LDB09054(Idelalisib) Idelalisib is indicated in the treatment of chronic lymphocytic leukemia (CLL), relapsed follicular B-cell non-Hodgkin lymphoma (FL), and relapsed small lymphocytic lymphoma (SLL). For the treatment of relapsed CLL, it is currently indicated as a second-line agent in combination with rituximab in patients for whom rituximab alone would be considered appropriate therapy due to other co-morbidities, while in the treatment of FL and SLL it is intended to be used in patients who have received at least two prior systemic therapies. View
41XDB00234(Reboxetine) For the treatment of clinical depression. View
478DB00701(Amprenavir) For the treatment of HIV-1 infection in combination with other antiretroviral agents. View
486DB00834(Mifepristone) For the medical termination of intrauterine pregnancy through 49 days' pregnancy. Also indicated to control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and are not candidates for surgery or have had unsuccessful surgery. View
4APDB06637(Dalfampridine) Dalfampridine is a neurofunctional modifier that helps improve walking speed in patients with multiple sclerosis (MS). View
4AXDB00260(Cycloserine) Used in combination with up to 5 other drugs as a treatment for Mycobacterium avium complex (MAC) and is also used to treat tuberculosis (TB). View
4CHDB13154(Parachlorophenol) Used as an intermediate in organic synthesis of dyes and drugs. Local antibacterial agent in root canal therapy, as topical antiseptic in ointments View
4DYDB06774(Capsaicin) The capsaicin 8% patch is indicated in the treatment of neuropathic pain associated with post-herpetic neuralgia. There are multiple topical capsaicin formulations available, including creams and solutions, indicated for temporary analgesia in muscle and join pain as well as neuropathic pain. View
4KODB00274(Cefmetazole) For the treatment of infections caused by susceptible organisms. View
4LEDB00753(Isoflurane) For induction and maintenance of general anesthesia. View
4MKDB09063(Ceritinib) Ceritinib is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib. This indication is approved under accelerated approval based on tumor response rate and duration of response. An improvement in survival or disease-related symptoms has not been established. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials. View
4PZDB01213(Fomepizole) Antizol is indicated as an antidote for ethylene glycol (such as antifreeze) or methanol poisoning, or for use in suspected ethylene glycol or methanol ingestion, either alone or in combination with hemodialysis View
4TXDB01241(Gemfibrozil) For treatment of adult patients with very high elevations of serum triglyceride levels (types IV and V hyperlipidemia) who are at risk of developing pancreatitis (inflammation of the pancreas) and who do not respond adequately to a strict diet. View
4YHDB00661(Verapamil) For the treatment of hypertension, angina, and cluster headache prophylaxis. View
505DB00379(Mexiletine) For the treatment of ventricular tachycardia and symptomatic premature ventricular beats, and prevention of ventricular fibrillation. View
51GDB00798(Gentamicin) For treatment of serious infections caused by susceptible strains of the following microorganisms: <i>P. aeruginosa</i>, <i>Proteus</i> species (indole-positive and indole-negative), <i>E. coli</i>, <i>Klebsiella-Enterobactor-Serratia</i> species, <i>Citrobacter</i> species and <i>Staphylococcus</i> species (coagulase-positive and coagulase-negative). View
5AEDB00928(Azacitidine) For treatment of patients with the following French-American-British myelodysplastic syndrome subtypes: refractory anemia or refractory anemia with ringed sideroblasts (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts, refractory anemia with excess blasts in transformation (now classified as acute myelogenous leukemia with multilineage dysplasia), and chronic myelomonocytic leukemia. View
5CHDB01628(Etoricoxib) For the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. View
5D5DB08834(Tauroursodeoxycholic acid) Used in the treatment of cholesterol gallstones. Tauroursodeoxycholic acid is also being investigated for use in several conditions such as Primary Biliary Cirrhosis (PBC), insulin resistance, amyloidosis, Cystic Fibrosis, Cholestasis, and Amyotrophic Lateral Sclerosis. View
5FWDB01064(Isoprenaline) For the treatment of mild or transient episodes of heart block that do not require electric shock or pacemaker therapy also used in management of asthma and chronic bronchitis View
5OGDB05015(Belinostat) Belinostat is indicated for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) with manageable safety profile. It is a potential alternative therapy for patients who did not experience adequate response to first-line drugs for PTCL. It can be used in patients with baseline thrombocytopenia [A19161]. View
657DB00740(Riluzole) For the treatment of amyotrophic lateral sclerosis (ALS, Lou Gehrig's Disease) View
65BDB06414(Etravirine) Indicated as an adjunct therapy in the treatment of adult HIV-1 infections resistant to therapy with other NNRTIs and antiretroviral agents. View
68HDB01001(Salbutamol);DB13139(Levosalbutamol) For symptomatic relief and prevention of bronchospasm due to bronchial asthma, chronic bronchitis, and other chronic bronchopulmonary disorders such as COPD. ;Levosalbutamol's bronchodilator properties give it indications in treatment of COPD (chronic obstructive pulmonary disease, also known as chronic obstructive lung disease) and asthma. View
68PDB00215(Citalopram);DB01175(Escitalopram) For the treatment of depression. Off-label indications include: treatment of mild dementia-associated agitation in nonpsychotic patients, smoking cessation, ethanol abuse, obsessive-compulsive disorder (OCD) in children, and diabetic neuropathy [FDA label]. ;Labeled indications include major depressive disorder (MDD) and generalized anxiety disorder (GAD). Unlabeled indications include treatment of mild dementia-associated agitation in nonpsychotic patients. View
6ELDB01041(Thalidomide) For the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL). Also for use as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrence. View
6J3DB09218(Clonixin) Used primarily in the treatment of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation. View
6JPDB01094(Hesperetin) For lowering cholesterol and, possibly, otherwise favorably affecting lipids. <i>In vitro</i> research also suggests the possibility that hesperetin might have some anticancer effects and that it might have some anti-aromatase activity, as well as activity again. View
6K9DB08871(Eribulin) For the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic cancer. View
6LHDB06795(Mafenide) Mafenide is indicated in the treatment of severe burns. View
6T0DB00724(Imiquimod) For the topical treatment of clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses on the face or scalp in immunocompetent adults. Also indicated for the treatment of external genital and perianal warts/condyloma acuminata in individuals 12 years old and above. View
6U9DB00393(Nimodipine) For use as an adjunct to improve neurologic outcome following subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms by reducing the incidence and severity of ischemic deficits. View
6UBDB00381(Amlodipine) For the treatment of hypertension and chronic stable angina. View
6V8DB09570(Ixazomib) Ixazomib is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. View
6ZPDB08883(Perampanel) Used in patients over 12 years old for the treatment of partial-onset seizures that may or may not occur with generalized seizures. View
6ZZDB11730(Ribociclib) Kisqali (ribociclib) is a selective cyclin-dependent kinase inhibitor, a class of drugs that help slow the progression of cancer by inhibiting two proteins called cyclin-dependent kinase 4 and 6 (CDK4/6). These proteins, when over-activated, can enable cancer cells to grow and divide too quickly. Targeting CDK4/6 with enhanced precision may play a role in ensuring that cancer cells do not continue to replicate uncontrollably. View
715DB01261(Sitagliptin) For use as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus. Also for use in patients with type 2 diabetes mellitus to improve glycemic control in combination with metformin or a PPARγ agonist (e.g., thiazolidinediones) when the single agent alone, with diet and exercise, does not provide adequate glycemic control. View
7V7DB00813(Fentanyl) For the treatment of cancer patients with severe pain that breaks through their regular narcotic therapy. View
803DB00227(Lovastatin) For management as an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemia. For primary prevention of coronary heart disease and to slow progression of coronary atherosclerosis in patients with coronary heart disease. View
84GDB06696(Arbekacin) Arbekacin is used for the short term treatment of multi-resistant bacterial infections, such as methicillin-resistant <i>Staphylococcus aureus</i> (MRSA). View
8CVDB00914(Phenformin) For the reatment of type II diabetes mellitus. View
8LXDB09198(Lobeglitazone) Lobeglitazone is an antidiabetic drug in the thiazolidinedione class of drugs. As an agonist for both PPARα and PPARγ, it works as an insulin sensitizer by binding to the PPAR receptors in fat cells and making the cells more responsive to insulin. It was approved by the Ministry of Food and Drug Safety (Korea) in 2013, and the postmarketing surveillance is on progress until 2019. View
8MODB00553(Methoxsalen) For the treatment of psoriasis and vitiligo View
8N6DB01132(Pioglitazone) Pioglitazone is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [FDA Label]. View
8NUDB00734(Risperidone) For the treatment of schizophrenia in adults and in adolescents, ages 13 to 17, and for the short-term treatment of manic or mixed episodes of bipolar I disorder in children and adolescents ages 10 to 17. May also be used to manage symptoms of inappropriate behavior due to aggression and/or psychosis in patients with severe dementia. View
8PRDB00715(Paroxetine) Labeled indications include: major depressive disorder (MDD), panic disorder with or without agoraphobia, obsessive-compulsive disorder (OCD), social anxiety disorder (social phobia), generalized anxiety disorder (GAD), post-traumatic stress disorder (PTSD), and premenstrual dysphoric disorder (PMDD). Unlabeled indications include: eating disorders, impulse control disorders, vasomotor symptoms of menopause, obsessive-compulsive disorder (OCD) in children, and mild dementia-associated agitation in nonpsychotic individuals. Brisdelle, which consists of paroxetine mesylate is indicated for the treatment of moderate to severe vasomotor symptoms (like hot flashes) associated with menopause. View
8QPDB00749(Etodolac) For acute and long-term management of signs and symptoms of osteoarthritis and rheumatoid arthritis, as well as for the management of pain. View
8QSDB00749(Etodolac) For acute and long-term management of signs and symptoms of osteoarthritis and rheumatoid arthritis, as well as for the management of pain. View
8W5DB01222(Budesonide) The oral capsule is used for the treatment of mild to moderate active Crohn's disease. The oral tablet is used for induction of remission in patients with active, mild to moderate ulcerative colitis. The oral inhalation formulation is used for the treatment of asthma, non-infectious rhinitis (including hay fever and other allergies), and for treatment and prevention of nasal polyposis. View
95EDB00330(Ethambutol) For use, as an adjunct, in the treatment of pulmonary tuberculosis. View
95ZDB01296(Glucosamine) Glucosamine is usually used in the treatment of osteoarthritis, although its efficacy is still in question. View
9CRDB00523(Alitretinoin) For topical treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma. View
9DCDB06782(Dimercaprol) For the treatment of arsenic, gold and mercury poisoning. Indicated in acute lead poisoning when used concomitantly with edetate calcium disodium (DB00974). View
9F2DB01212(Ceftriaxone) For the treatment of the infections (respiratory, skin, soft tissue, UTI, ENT) caused by S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staph View
9KLDB09214(Dexketoprofen) For short-term treatment of mild to moderate pain, including dysmenorrhoea. View
9PLDB01085(Pilocarpine) For the treatment of radiation-induced dry mouth (xerostomia) and symptoms of dry mouth in patients with Sj&ouml;grens syndrome. View
9RADB00307(Bexarotene) Used orally for the treatment of skin manifestations of cutaneous T-cell lymphoma (CTCL) in patients who are refractory to at least one prior systemic therapy. Also used topically for the treatment of skin lesions in early (stage IA and IB) CTCL in patients who experience refractory or persistent disease with the use of other therapies or are intolerant of other therapies. View
9SCDB01238(Aripiprazole) For the treatment of schizophrenia and related psychotic disorders. View
9TPDB00444(Teniposide) Teniposide is used for the treatment of refractory acute lymphoblastic leukaemia View
9UQDB00357(Aminoglutethimide) For the suppression of adrenal function in selected patients with Cushing's syndrome, malignant neoplasm of the female breast, and carcinoma in situ of the breast. View
9V2DB00593(Ethosuximide) For the treatment of petit mal epilepsy. View
9WTDB01413(Cefepime) For the treatment of pneumonia (moderate to severe) caused by <i>Streptococcus pneumoniae</i>, including cases associated with concurrent bacteremia, <i>Pseudomonas aeruginosa</i>, <i>Klebsiella pneumoniae</i>, or <i>Enterobacter</i> species. Also for empiric treatment of febrile neutropenic patients and uncomplicated and complicated urinary tract infections (including pyelonephritis) caused by <i>Escherichia coli</i> or <i>Klebsiella pneumoniae</i>, when the infection is severe, or caused by <i>Escherichia coli</i>, <i>Klebsiella pneumoniae</i>, or <i>Proteus mirabilis</i>, when the infection is mild to moderate, including cases associated with concurrent bacteremia with these microorganisms. Also for the treatment of uncomplicated skin and skin structure infections caused by <i>Staphylococcus aureus</i> (methicillin-susceptible strains only) or <i>Streptococcus pyogenes</i> and complicated intra-abdominal infections (used in combination with metronidazole) caused by <i>Escherichia coli</i>, viridans group streptococci, <i>Pseudomonas aeruginosa</i>, <i>Klebsiella pneumoniae</i>, <i>Enterobacter</i> species, or <i>Bacteroides fragilis</i>. View
A80DB04942(Tamibarotene) Investigated for use/treatment in leukemia (unspecified). View
AB1DB01601(Lopinavir) Indicated in combination with other antiretroviral agents for the treatment of HIV-infection. View
AC2DB00787(Aciclovir) View
ACADB00513(Aminocaproic Acid) For use in the treatment of excessive postoperative bleeding. View
ACHDB03128(Acetylcholine) Used to obtain miosis of the iris in seconds after delivery of the lens in cataract surgery, in penetrating keratoplasty, iridectomy and other anterior segment surgery where rapid miosis may be required. View
ACRDB00284(Acarbose) For treatment and management of diabetes type II (used in combination therapy as a second or third line agent) View
ACTDB03166(Acetic acid) Used to treat infections in the ear canal. View
ADNDB00640(Adenosine) Used as an initial treatment for the termination of paroxysmal supraventricular tachycardia (PVST), including that associated with accessory bypass tracts, and is a drug of choice for terminating stable, narrow-complex supraventricular tachycardias (SVT). Also used as an adjunct to thallous chloride TI 201 myocardial perfusion scintigraphy (thallium stress test) in patients who are unable to exercise adequately, as well as an adjunct to vagal maneuvers and clinical assessment to establish a specific diagnosis of undefined, stable, narrow-complex SVT. View
AEGDB09352(Hydroxyamphetamine) Mydriatic agent (eye pupil dilatation) for diagnosis of ophthalmic nerve lesions. View
AERDB05812(Abiraterone) Used in combination with prednisone for the treatment of metastatic, castration-resistant prostate cancer. View
AG2DB08838(Agmatine) Agmatine is being studied experimentally for several indications such as cardioprotection, diabetes, decreased kidney function, neuroprotection (stroke, severe CNS injuries, epilepsy, glaucoma, and neuropathic pain), and psychiatric conditions (depression, anxiety, schizophrenia, and cognition). As an investigational drug, agamatine is being studied in a non-blinded prospective case study in the United States looking at patients who have been diagnosed with small fiber peripheral neuropathy. View
AGGDB00775(Tirofiban) For treatment, in combination with heparin, of acute coronary syndrome, including patients who are to be managed medically and those undergoing PTCA or atherectomy. View
AICDB00415(Ampicillin) For treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc View
AINDB00945(Acetylsalicylic acid) For use in the temporary relief of various forms of pain, inflammation associated with various conditions (including rheumatoid arthritis, juvenile rheumatoid arthritis, systemic lupus erythematosus, osteoarthritis, and ankylosing spondylitis), and is also used to reduce the risk of death and/or nonfatal myocardial infarction in patients with a previous infarction or unstable angina pectoris. View
AKNDB00479(Amikacin) For short-term treatment of serious infections due to susceptible strains of Gram-negative bacteria, including Pseudomonas species, Escherichia coli, species of indole-positive and indole-negative Proteus, Providencia species, Klebsiella-Enterobacter-Serratia species, and Acinetobacter (Mima-Herellea) species. Amikacin may also be used to treat Mycobacterium avium and Mycobacterium tuberculosis infections. View
ALEDB00668(Epinephrine) Used to treat anaphylaxis and sepsis. Also one of the body's main adrenergic neurotransmitters. View
AM2DB04626(Apramycin) For the treatment of bacterial infections in animals. View
AMHDB00302(Tranexamic Acid) For use in patients with hemophilia for short term use (two to eight days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction. It can also be used for excessive bleeding in menstruation, surgery, or trauma cases. View
AMJDB06218(Lacosamide) Lacosamide is indicated for adjunctive therapy for partial onset seizures in patients with epilepsy over 17 years old. Injection is indicated for short term use when oral therapy is not feasible. View
AMRDB00594(Amiloride) For use as adjunctive treatment with thiazide diuretics or other kaliuretic-diuretic agents in congestive heart failure or hypertension. View
ANWDB01025(Amlexanox) Used as a paste in the mouth to treat aphthous ulcers (canker sores). View
AOQDB01117(Atovaquone) For the treatment or prevention of <i>Pneumocystis carinii</i> pneumonia in patients who are intolerant to trimethoprim-sulfamethoxazole (TMP-SMX). Also indicated for the acute oral treatment of mild to moderate PCP in patients who are intolerant to TMP-SMX. View
AQ4DB00530(Erlotinib) For the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen. Also for use, in combination with gemcitabine, as the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer. View
AR3DB00987(Cytarabine) For the treatment of acute non-lymphocytic leukemia, acute lymphocytic leukemia and blast phase of chronic myelocytic leukemia. View
ASCDB00126(Vitamin C) Used to treat vitamin C deficiency, scurvy, delayed wound and bone healing, urine acidification, and in general as an antioxidant. It has also been suggested to be an effective antiviral agent. View
ASDDB01536(4-Androstenedione) View
ASRDB03006(Arsanilic acid) An arsenical which has been used as a feed additive for enteric conditions in pigs and poultry. It causes blindness and is ototoxic and nephrotoxic in animals. [PubChem] View
ASWDB00276(Amsacrine) For treatment of acute myeloid leukaemia. View
AVLDB05266(Ibudilast) For the treatment of multiple sclerosis, asthma, and cerebrovascular disease. View
AWYDB06594(Agomelatine) Agomelatine is indicated for the treatment of major depressive episodes in adults. View
AXIDB06626(Axitinib) Used in kidney cell cancer and investigated for use/treatment in pancreatic and thyroid cancer. View
AY6DB06155(Rimonabant) For use in conjunction with diet and exercise for patients with a body mass index greater than 30 kg/m<sup>2</sup>, or patients wih a BMI greater than 27 kg/m<sup>2</sup> with associated risk factors, such as type 2 diabetes or dyslipidaemia. View
AZ1DB00548(Azelaic Acid) For the topical treatment of mild-to-moderate inflammatory acne vulgaris. View
AZMDB00819(Acetazolamide) For adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies; chronic simple (open-angle) glaucoma View
AZZDB00495(Zidovudine) Used in combination with other antiretroviral agents for the treatment of human immunovirus (HIV) infections. View
B40DB01577(Methamphetamine) For the treatment of Attention Deficit Disorder with Hyperactivity (ADHD) and exogenous obesity. View
B41DB01454(3,4-Methylenedioxymethamphetamine) View
B49DB01268(Sunitinib) For the treatment of advanced renal cell carcinoma as well as the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. View
BAXDB00398(Sorafenib) Sorafenib is indicated for the treatment of unresectable hepatocellular carcinoma and advanced renal cell carcinoma. View
BBIDB01118(Amiodarone) Intravenously, for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy. Orally, for the treatment of life-threatening recurrent ventricular arrhythmias such as recurrent ventricular fibrillation and recurrent hemodynamically unstable ventricular tachycardia. View
BCZDB06614(Peramivir) Investigated for use/treatment in influenza. View
BEPDB01244(Bepridil) For the treatment of hypertension, and chronic stable angina (classic effort-associated angina). View
BEZDB03793(Benzoic Acid) A fungistatic compound that is widely used as a food preservative. It is conjugated to GLYCINE in the liver and excreted as hippuric acid. As the sodium salt form, sodium benzoate is used as a treatment for urea cycle disorders due to its ability to bind amino acids. This leads to excretion of these amino acids and a decrease in ammonia levels. Recent research shows that sodium benzoate may be beneficial as an add-on therapy (1 gram/day) in schizophrenia. Total Positive and Negative Syndrome Scale scores dropped by 21% compared to placebo. View
BFQDB00710(Ibandronate) For the treatment and prevention of osteoporosis in postmenopausal women. View
BHADB00233(Aminosalicylic Acid) For the treatment of tuberculosis View
BHSDB00360(Sapropterin) For the treatment of tetrahydrobiopterin (BH4) deficiency. View
BJMDB06335(Saxagliptin) Treatment of type 2 diabetes mellitus to improve glycemic control in combination with other agents or as monotherapy. View
BL1DB00808(Indapamide) For the treatment of hypertension, alone or in combination with other antihypertensive drugs, as well as for the treatment of salt and fluid retention associated with congestive heart failure or edema from pregnancy (appropriate only in the management of edema of pathologic origin during pregnancy when clearly needed). Also used for the management of edema as a result of various causes. View
BO2DB00188(Bortezomib) For treatment of multiple myeloma in patients who have not been successfully treated with at least two previous therapies. View
BQ1DB08903(Bedaquiline) Bedaquiline is indicated as part of combination therapy in adults (≥ 18 years) with pulmonary multi-drug resistant tuberculosis (MDR-TB). View
BRLDB00412(Rosiglitazone) Rosiglitazone is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. View
BUWDB00392(Ethopropazine) For use in the treatment of Parkinson's disease and also used to control severe reactions to certain medicines such as reserpine. View
BZ1DB01194(Brinzolamide) For the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. View
BZMDB00676(Benzyl Benzoate) Used to kill lice and the mites responsible for the skin condition scabies. View
C04DB00671(Cefixime) For use in the treatment of the following infections when caused by susceptible strains of the designated microorganisms: (1) uncomplicated urinary tract infections caused by <i>Escherichia coli</i> and <i>Proteus mirabilis</i>, (2) otitis media caused by <i>Haemophilus influenzae</i> (beta-lactamase positive and negative strains), <i>Moraxella catarrhalis</i> (most of which are beta-lactamase positive), and <i>S. pyogenes</i>, (3) pharyngitis and tonsillitis caused by <i>S. pyogenes</i>, (4) acute bronchitis and acute exacerbations of chronic bronchitis caused by <i>Streptococcus pneumoniae</i> and <i>Haemophilus influenzae</i> (beta-lactamase positive and negative strains), and (5) uncomplicated gonorrhea (cervical/urethral) caused by <i>Neisseria gonorrhoeae</i> (penicillinase- and non-penicillinase-producing strains). View
C2FDB11256(Levomefolic acid) Treatment and prevention of folate deficiency Antidote against folic acid antagonists View
C3DDB06202(Lasofoxifene) Investigated for use/treatment in osteoporosis and female hormonal deficiencies/abnormalities. View
C41DB09026(Aliskiren) For the treatment of hypertension, to lower blood pressure. View
C5EDB09028(Cytisine) Indicated for use in smoking cessation. View
C7HDB00434(Cyproheptadine) For treatment of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis due to inhalant allergens and foods, mild uncomplicated allergic skin manifestations of urticaria and angioedema, amelioration of allergic reactions to blood or plasma, cold urticaria, dermatographism, and as therapy for anaphylactic reactions adjunctive to epinephrine. View
CA4DB04839(Cyproterone acetate) For the palliative treatment of patients with advanced prostatic carcinoma. View
CAMDB01744(Camphor) A bicyclic monoterpene ketone found widely in plants, especially cinnamomum camphora. It is used topically as a skin antipruritic and as an anti-infective agent. [PubChem] View
CBLDB00291(Chlorambucil) For treatment of chronic lymphatic (lymphocytic) leukemia, childhood minimal-change nephrotic syndrome, and malignant lymphomas including lymphosarcoma, giant follicular lymphoma, Hodgkin's disease, non-Hodgkin's lymphomas, and Waldenström’s Macroglobulinemia. View
CCSDB04339(Carbocisteine) Used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis. View
CDXDB00380(Dexrazoxane) For reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin hydrochloride dose of 300 mg/m^2 and would benefit from continued doxorubicin therapy. Also approved for the treatment of extravasation from intravenous anthracyclines. View
CE3DB00493(Cefotaxime) Used to treat gonorrhoea, meningitis, and severe infections including infections of the kidney (pyelonephritis) and urinary system. Also used before an operation to prevent infection after surgery. View
CE9DB06811(Polidocanol) Polidocanol is a sclerosing agent indicated to treat uncomplicated spider veins and uncomplicated reticular veins in the lower extremity. View
CEDDB04133(Degraded Cephaloridine) View
CELDB00482(Celecoxib) For the relief and management of osteoarthritis (OA), rheumatoid arthritis (RA), juvenile rheumatoid arthritis (JRA), ankylosing spondylitis, acute pain, primary dysmenorrhea and oral adjunct to usual care for patients with familial adenomatous polyposis [FDA label]. View
CFBDB00631(Clofarabine) For the treatment of pediatric patients 1 to 21 years old with relapsed or refractory acute lymphocytic (lymphoblastic) leukemia after at least two prior regimens. It is designated as an orphan drug by the FDA for this use. View
CFFDB00201(Caffeine) For management of fatigue, orthostatic hypotension, and for the short term treatment of apnea of prematurity in infants. View
CFXDB01331(Cefoxitin) For the treatment of serious infections caused by susceptible strains microorganisms. View
CGEDB00758(Clopidogrel) For the reduction of atherosclerotic events (myocardial infarction, stroke, and vascular death) in patients with atherosclerosis documented by recent stroke, recent myocardial infarction, or established peripheral arterial disease. View
CHCDB05990(Obeticholic acid) Investigated for use/treatment in liver disease. View
CHDDB02659(Cholic Acid) Oral cholic acid is indicated for: treatment of bile acid synthesis disorders due to single enzyme defects; and as adjunctive treatment of peroxisomal disorders including Zellweger spectrum disorders in patients who exhibit manifestations of liver disease, steatorrhea or complications from decreased fat soluble vitamin absorption. View
CIADB00820(Tadalafil) Used for the treatment of erectile dysfunction. View
CILDB01597(Cilastatin) Combined intravenously with imipenem in order to protect it from dehydropeptidase and prolong its antibacterial effect. View
CIODB03849(Cilomilast) Investigated for use/treatment in chronic obstructive pulmonary disease (COPD). View
CL6DB00257(Clotrimazole) For the local treatment of oropharyngeal candidiasis and vaginal yeast infections, also used in fungal infections of the skin such as ringworm, athlete's foot, and jock itch. View
CL9DB00242(Cladribine) For the treatment of active hairy cell leukemia (leukemic reticuloendotheliosis) as defined by clinically significant anemia, neutropenia, thrombocytopenia, or disease-related symptoms. Also used as an alternative agent for the treatment of chronic lymphocytic leukemia (CLL), low-grade non-Hodgkin's lymphoma, and cutaneous T-cell lymphoma. View
CLMDB00446(Chloramphenicol) Used in treatment of cholera, as it destroys the vibrios and decreases the diarrhea. It is effective against tetracycline-resistant vibrios. It is also used in eye drops or ointment to treat bacterial conjunctivitis. View
CLQDB00608(Chloroquine) For the suppressive treatment and for acute attacks of malaria due to P. vivax, P.malariae, P. ovale, and susceptible strains of P. falciparum, Second-line agent in treatment of Rheumatoid Arthritis View
CLSDB00456(Cefalotin) Used to prevent infection during surgery and to treat many kinds of infections of the blood, bone or joints, respiratory tract, skin, and urinary tract. View
CLUDB00575(Clonidine) May be used as an adjunct in the treatment of hypertension, as an epidural infusion as an adjunct treatment in the management of severe cancer pain that is not relieved by opiate analgesics alone, for differential diagnosis of pheochromocytoma in hypertensive patients, prophylaxis of vascular migraine headaches, treatment of severe dysmenorrhea, management of vasomotor symptoms associated with menopause, rapid detoxification in the management of opiate withdrawal, treatment of alcohol withdrawal used in conjunction with benzodiazepines, management of nicotine dependence, topical use to reduce intraocular pressure in the treatment of open-angle and secondary glaucoma and hemorrhagic glaucoma associated with hypertension, and in the treatment of attention-deficit hyperactivity disorder (ADHD). View
CLWDB00356(Chlorzoxazone) For the relief of discomfort associated with acute painful musculoskeletal conditions. View
CLYDB01190(Clindamycin) For the treatment of serious infections caused by susceptible anaerobic bacteria, including Bacteroides spp., Peptostreptococcus, anaerobic streptococci, Clostridium spp., and microaerophilic streptococci. May be useful in polymicrobic infections such as intra-abdominal or pelvic infections, osteomyelitis, diabetic foot ulcers, aspiration pneumonia and dental infections. May also be used to treat MSSA and respiratory infections caused by S. pneumoniae and S. pyogenes in patients who are intolerant to other indicated antibiotics or who are infected with resistant organism. May be used vaginally to treat vaginosis caused by Gardnerella vaginosa. Clindamycin reduces the toxin producing effects of S. aureus and S. pyogenes and as such, may be particularly useful for treating necrotizing fasciitis. May be used topically to treat acne. View
COCDB00907(Cocaine) For the introduction of local (topical) anesthesia of accessible mucous membranes of the oral, laryngeal and nasal cavities. View
COXDB00580(Valdecoxib) For the treatment of osteoarthritis and dysmenorrhoea View
CP0DB00762(Irinotecan) For the treatment of metastatic colorectal cancer (first-line therapy when administered with 5-fluorouracil and leucovorin). Also used in combination with cisplatin for the treatment of extensive small cell lung cancer. Irinotecan is currently under investigation for the treatment of metastatic or recurrent cervical cancer. Also used in combination with fluorouracil and leucovorin for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. View
CP6DB00205(Pyrimethamine) For the treatment of toxoplasmosis and acute malaria; For the prevention of malaria in areas non-resistant to pyrimethamine View
CPFDB00537(Ciprofloxacin) For the treatment of the following infections caused by susceptible organisms: urinary tract infections, acute uncomplicated cystitis, chronic bacterial prostatitis, lower respiratory tract infections, acute sinusitis, skin and skin structure infections, bone and joint infections, complicated intra-abdominal infections (used in combination with metronidazole), infectious diarrhea, typhoid fever (enteric fever), uncomplicated cervical and urethral gonorrhea, and inhalational anthrax (post-exposure). View
CQADB00613(Amodiaquine) For treatment of acute malarial attacks in non-immune subjects. View
CQLDB04815(Clioquinol) Used as a topical antifungal treatment. View
CQNDB01244(Bepridil) For the treatment of hypertension, and chronic stable angina (classic effort-associated angina). View
CRNDB00148(Creatine) For nutritional supplementation, also for treating dietary shortage or imbalance. View
CSCDB03313(Cephalosporin C) View
CTCDB09093(Chlortetracycline) Chlortetracycline is a tetracycline antibiotic, the first tetracycline to be identified. It was discovered in 1945 by Benjamin Minge Duggar working at Lederle Laboratories under the supervision of Yellapragada Subbarow. Duggar identified the antibiotic as the product of an actinomycete he cultured from a soil sample collected from Sanborn Field at the University of Missouri. The organism was named Streptomyces aureofaciens and the isolated drug, Aureomycin, because of their golden color. View
CTXDB00675(Tamoxifen) Tamoxifen is indicated for the treatment of metastatic breast cancer in women and men and ductal carcinoma in Situ. View
CTYDB01211(Clarithromycin) An alternative medication for the treatment of acute otitis media caused by <i>H. influenzae, M. catarrhalis, or S. pneumoniae</i> in patients with a history of type I penicillin hypersensitivity. Also for the treatment of pharyngitis and tonsillitis caused by susceptible <i>Streptococcus pyogenes</i>, as well as respiratory tract infections including acute maxillary sinusitis, acute bacterial exacerbations of chronic bronchitis, mild to moderate community-acquired pneuomia, Legionnaires' disease, and pertussis. Other indications include treatment of uncomplicated skin or skin structure infections, helicobacter pylori infection, duodenal ulcer disease, bartonella infections, early Lyme disease, and encephalitis caused by <i>Toxoplasma gondii</i> (in HIV infected patients in conjunction with pyrimethamine). Clarithromycin may also decrease the incidence of cryptosporidiosis, prevent the occurence of α-hemolytic (viridans group) streptococcal endocarditis, as well as serve as a primary prevention for <i>Mycobacterium avium</i> complex (MAC) bacteremia or disseminated infections (in adults, adolescents, and children with advanced HIV infection). View
CU9DB01336(Metocurine) Metocurine is a muscle relaxant. View
CVDDB01136(Carvedilol) For the treatment of mild or moderate (NYHA class II or III) heart failure of ischemic or cardiomyopathic origin. View
CVIDB00406(Gentian Violet) For the treatment of bacterial and fungal infections inside the mouth (thrush) and skin, also for the prevention of transmission of Chagas' disease (as a blood additive). View
CWBDB00889(Granisetron) For the prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy (including high dose cisplatin), postoperation, and radiation (including total body irradiation and daily fractionated abdominal radiation). View
CXQDB00245(Benzatropine) For use as an adjunct in the therapy of all forms of parkinsonism and also for use in the control of extrapyramidal disorders due to neuroleptic drugs. View
CXXDB01242(Clomipramine) May be used to treat obsessive-compulsive disorder and disorders with an obsessive-compulsive component (e.g. depression, schizophrenia, Tourette’s disorder). View
CYSDB00151(L-Cysteine) For the prevention of liver damage and kidney damage associated with overdoses of acetaminophen View
CYZDB00606(Cyclothiazide) Cyclothiazide is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. It is also indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension. View
CZEDB00341(Cetirizine) For the relief of symptoms associated with seasonal allergic rhinitis, perennial allergic rhinitis and the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria View
D16DB00293(Raltitrexed) For the treatment of malignant neoplasm of colon and rectum View
D27DB07615(Tranilast) For the treatment of bronchial asthma, keloid and hypertrophic scar, and allergic disorders such as asthma, allergic rhinitis and atopic dermatitis. View
D2VDB00153(Ergocalciferol) For use in the management of hypocalcemia and its clinical manifestations in patients with hypoparathyroidism, as well as for the treatment of familial hypophosphatemia (vitamin D resistant rickets). This drug has also been used in the treatment of nutritional rickets or osteomalacia, vitamin D dependent rickets, rickets or osteomalacia secondary to long-term high dose anticonvulsant therapy, early renal osteodystrophy, osteoporosis (in conjunction with calcium), and hypophosphatemia associated with Fanconi syndrome (with treatment of acidosis). View
D7VDB01142(Doxepin) **Oral: ** View
D8ZDB06697(Artemether) Artemether and lumefantrine combination therapy is indicated for the treatment of acute uncomplicated malaria caused by <i>Plasmodium falciparum</i>, including malaria acquired in chloroquine-resistant areas. May also be used to treat uncomplicated malaria when the <i>Plasmodium</i> species has not been identified. Indicated for use in adults and children greater than 5 kg. View
D95DB09274(Artesunate) For the treatment of severe malaria caused by *Plasmodium falciparum* in adults and children [L891] View
DAHDB01235(Levodopa) For the treatment of idiopathic Parkinson's disease (Paralysis Agitans), postencephalitic parkinsonism, symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication, and manganese intoxication. View
DB8DB06616(Bosutinib) Treatment of chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with resistance or intolerance to prior therapy in adult patients. View
DCFDB00552(Pentostatin) For the treatment of hairy cell leukaemia refractory to alpha interferon. View
DCKDB00583(L-Carnitine) For treatment of primary systemic carnitine deficiency, a genetic impairment of normal biosynthesis or utilization of levocarnitine from dietary sources, or for the treatment of secondary carnitine deficiency resulting from an inborn error of metabolism such as glutaric aciduria II, methyl malonic aciduria, propionic acidemia, and medium chain fatty acylCoA dehydrogenase deficiency. Used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias. Parenteral levocarnitine is indicated for the prevention and treatment of carnitine deficiency in patients with end-stage renal disease. View
DESDB00255(Diethylstilbestrol) Used in the treatment of prostate cancer. Previously used in the prevention of miscarriage or premature delivery in pregnant women prone to miscarriage or premature delivery. View
DEXDB00443(Betamethasone);DB01234(Dexamethasone) Topical use (cream, lotion and ointment): for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. ;<B>Injection:</B> for the treatment of endocrine disorders, rheumatic D=disorders, collagen diseases, dermatologic diseases, allergic statesc, ophthalmic diseases, gastrointestinal diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, cerebral edema. View
DGXDB00390(Digoxin) For the treatment and management of congestive cardiac insufficiency, arrhythmias and heart failure. View
DHIDB00117(L-Histidine) The actions of supplemental L-histidine are entirely unclear. It may have some immunomodulatory as well as antioxidant activity. L-histidine may be indicated for use in some with rheumatoid arthritis. It is not indicated for treatment of anemia or uremia or for lowering serum cholesterol. View
DIFDB00586(Diclofenac) For the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthritis. View
DLUDB08930(Dolutegravir) Dolutegravir is indicated in combination with other antiretroviral agents for the treatment of patients with HIV-1 infection that comply with the characteristics of being adults or children aged 12 years and older and present at least a weight of 40 kg.[A7520] The FDA combination therapy approval of dolutegravir and rilpivirine is indicated for adults with HIV-1 infections whose virus is currently suppressed (< 50 copies/ml) on a stable regimen for at least six months, without history of treatment failure and no known substitutions associated to resistance to any of the two components of the therapy.[L1031] View
DM1DB00694(Daunorubicin) For remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults. View
DM2DB00445(Epirubicin);DB00997(Doxorubicin) For use as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer.;Doxorubicin is used to produce regression in disseminated neoplastic conditions like acute lymphoblastic leukemia, acute myeloblastic leukemia, Wilms’ tumor, neuroblastoma, soft tissue and bone sarcomas, breast carcinoma, ovarian carcinoma, transitional cell bladder carcinoma, thyroid carcinoma, gastric carcinoma, Hodgkin’s disease, malignant lymphoma and bronchogenic carcinoma in which the small cell histologic type is the most responsive compared to other cell types. Doxorubicin is also indicated for use as a component of adjuvant therapy in women with evidence of axillary lymph node involvement following resection of primary breast cancer. View
DM5DB01177(Idarubicin) For the treatment of acute myeloid leukemia (AML) in adults. This includes French-American-British (FAB) classifications M1 through M7. View
DMEDB01245(Decamethonium) For use as a skeletal muscle relaxant View
DMODB06243(Eflornithine) Eflornithine is indicated in the treatment of facial hirsutism (excessive hair growth). View
DOLDB01764(Dalfopristin) For the treatment of bacterial infections (usually in combination with quinupristin). View
DP0DB00280(Disopyramide) For the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, ventricular pre-excitation and cardiac dysrhythmias. It is a Class Ia antiarrhythmic drug. View
DR7DB01072(Atazanavir) Used in combination with other antiretroviral agents for the treatment of HIV-1 infection, as well as postexposure prophylaxis of HIV infection in individuals who have had occupational or nonoccupational exposure to potentially infectious body fluids of a person known to be infected with HIV when that exposure represents a substantial risk for HIV transmission. View
DSFDB01189(Desflurane) For use as an inhalation agent for induction and/or maintenance of anesthesia for inpatient and outpatient surgery in adults. View
DSMDB01151(Desipramine) For relief of symptoms in various depressive syndromes, especially endogenous depression. It has also been used to manage chronic peripheral neuropathic pain, as a second line agent for the management of anxiety disorders (e.g. panic disorder, generalized anxiety disorder), and as a second or third line agent in the ADHD management. View
DVADB00161(L-Valine) Promotes mental vigor, muscle coordination, and calm emotions. May also be of use in a minority of patients with hepatic encephalopathy and in some with phenylketonuria. View
DX2DB00384(Triamterene) For the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and the nephrotic syndrome; also in steroid-induced edema, idiopathic edema, and edema due to secondary hyperaldosteronism. View
DX4DB00352(Tioguanine) For remission induction and remission consolidation treatment of acute nonlymphocytic leukemias. View
DXCDB03619(Deoxycholic Acid) For improvement in appearance of moderate to severe fullness associated with submental fat in adults. View
DXTDB00254(Doxycycline) Doxycycline is indicated for use in respiratory tract infections caused by Mycoplasma pneumoniae, Haemophilus influenzae, Streptococcus pneumoniae, Legionella spp., or Klebsiella spp. It is also used for prophylaxis of malaria. Doxycycline is indicated for a variety of bacterial infections, from Mycobacterium fortuitum and M. marinum, to susceptible E. coli and Brucella spp. It can be used as an alternative to treating plague, tetanus, Campylobacter fetus View
DZPDB00829(Diazepam) Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome. View
E20DB00843(Donepezil) For the palliative treatment of mild to moderate dementia of the Alzheimer's type. View
EAADB00903(Etacrynic acid) For the treatment of high blood pressure and edema caused by diseases like congestive heart failure, liver failure, and kidney failure. View
ECLDB01127(Econazole) For topical application in the treatment of tinea pedis, tinea cruris, and tinea corporis caused by <i>Trichophyton rubrum</i>, <i>Trichophyton mentagrophytes</i>, <i>Trichophyton tonsurans</i>, <i>Microsporum canis</i>, <i>Microsporum audouini</i>, <i>Microsporum gypseum</i>, and <i>Epidermophyton floccosum</i>, in the treatment of cutaneous candidiasis, and in the treatment of tinea versicolor. View
ECNDB01127(Econazole) For topical application in the treatment of tinea pedis, tinea cruris, and tinea corporis caused by <i>Trichophyton rubrum</i>, <i>Trichophyton mentagrophytes</i>, <i>Trichophyton tonsurans</i>, <i>Microsporum canis</i>, <i>Microsporum audouini</i>, <i>Microsporum gypseum</i>, and <i>Epidermophyton floccosum</i>, in the treatment of cutaneous candidiasis, and in the treatment of tinea versicolor. View
EDPDB00599(Thiopental) For use as the sole anesthetic agent for brief (15 minute) procedures, for induction of anesthesia prior to administration of other anesthetic agents, to supplement regional anesthesia, to provide hypnosis during balanced anesthesia with other agents for analgesia or muscle relaxation, for the control of convulsive states during or following inhalation anesthesia or local anesthesia, in neurosurgical patients with increased intracranial pressure, and for narcoanalysis and narcosynthesis in psychiatric disorders. View
EDRDB01010(Edrophonium) For the differential diagnosis of myasthenia gravis and as an adjunct in the evaluation of treatment requirements in this disease. It may also be used for evaluating emergency treatment in myasthenic crises. View
EDTDB00974(Edetic Acid) For the reduction of blood levels and depot stores of lead in lead poisoning (acute and chronic) and lead encephalopathy, in both pediatric populations and adults. View
EF2DB01041(Thalidomide) For the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL). Also for use as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrence. View
EFZDB00625(Efavirenz) For use in combination treatment of HIV infection (AIDS) View
ELVDB09101(Elvitegravir) Elvitegravir in combination with an HIV protease inhibitor coadministered with ritonavir and with other antiretroviral drug(s) is indicated for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults. View
EMHDB11363(Alectinib) Alectinib is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive, metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib. This indication is approved under accelerated approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials. View
EPADB00159(Icosapent) EPA can be used for lowering elevated triglycerides in those who are hyperglyceridemic. In addition, EPA may play a therapeutic role in patients with cystic fibrosis by reducing disease severity and may play a similar role in type 2 diabetics in slowing the progression of diabetic nephropathy. View
EQIDB02187(Equilin) For the treatment of moderate to severe vasomotor symptoms associated with the menopause, atrophic vaginitis, osteoporosis, hypoestrogenism due to hypogonadism, castration, primary ovarian failure, breast cancer (for palliation only), and Advanced androgen-dependent carcinoma of the prostate (for palliation only) View
ERMDB00696(Ergotamine) For use as therapy to abort or prevent vascular headache, e.g., migraine, migraine variants, or so called "histaminic cephalalgia". View
ERYDB00199(Erythromycin) For use in the treatment of infections caused by susceptible strains of microorganisms in the following diseases: respiratory tract infections (upper and lower) of mild to moderate degree, pertussis (whooping cough), as adjunct to antitoxin in infections due to <i>Corynebacterium diphtheriae</i>, in the treatment of infections due to <i>Corynebacterium minutissimum</i>, intestinal amebiasis caused by <i>Entamoeba histolytica</i>, acute pelvic inflammatory disease caused by <i>Neisseria gonorrhoeae</i>, skin and soft tissue infections of mild to moderate severity caused by <i>Streptococcus pyogenes</i> and <i>Staphylococcus aureus</i>, primary syphilis caused by <i>Treponema pallidum</i>, infections caused by <i>Chlamydia trachomatis</i>, nongonococcal urethritis caused by <i>Ureaplasma urealyticum</i>, and Legionnaires' disease caused by <i>Legionella pneumophila</i>. View
ESLDB04573(Estriol) Used as a test to determine the general health of an unborn fetus. View
ESTDB00783(Estradiol) Estradiol is indicated for the treatment of moderate to severe vasomotor symptoms and vulvar and vaginal atrophy due to menopause, for the treatment of hypoestrogenism due to hypogonadism, castration, or primary ovarian failure, and for the prevention of post-menopausal osteoarthritis. It is also used for the treatment of breast cancer (for palliation only) in appropriately selected women and men with metastatic disease, and for the treatment of advanced androgen-dependent carcinoma of the prostate (for palliation only). View
ETSDB00869(Dorzolamide) For the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Also used prophylatically for the inhibition of perioperative IOP increase (before neodynium yttrium aluminum garnet laser posterior capsulotomy). View
ETVDB00879(Emtricitabine) Indicated, in combination with other antiretroviral agents, for the treatment of HIV-1 infection in adults and for postexposure prophylaxis of HIV infection in health care workers and others exposed occupationally or nonoccupationally via percutaneous injury or mucous membrane or nonintact skin contact with blood, tissues, or other body fluids associated with risk for transmission of the virus. View
EU7DB00478(Rimantadine) For the prophylaxis and treatment of illness caused by various strains of influenza A virus in adults. View
EUIDB05239(Cobimetinib) For the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation. Cobimetinib is used in combination with vemurafenib, a BRAF inhibitor. View
EV1DB01113(Papaverine) For the treatment of impotence and vasospasms. View
EVPDB00773(Etoposide) For use in combination with other chemotherapeutic agents in the treatment of refractory testicular tumors and as first line treatment in patients with small cell lung cancer. Also used to treat other malignancies such as lymphoma, non-lymphocytic leukemia, and glioblastoma multiforme. View
EXMDB00990(Exemestane) For the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy. View
EY4DB11371(Alfaxalone) Alfaxalone, also known as alphaxalone or alphaxolone, is a neuroactive steroid and general anaesthetic. It is used in veterinary practice under the trade name Alfaxan, and is licensed for use in both dogs and cats. Along with alfadolone, it is also one of the constituents of anesthetic drug mixture althesin. View
EZLDB00311(Ethoxzolamide) For use in the treatment of duodenal ulcers, as a diuretic, and in the treatment of glaucoma, and may also be useful in the treatment of seizures associated with epilepsy. View
F9EDB01610(Valganciclovir) Valganciclovir is an antiviral medication used for the treatment of cytomegalovirus infections. View
FCNDB00828(Fosfomycin) For the treatment of uncomplicated urinary tract infections (acute cystitis) in women due to susceptible strains of <i>Escherichia coli</i> and <i>Enterococcus faecalis</i>. View
FFODB11596(Levoleucovorin) Levoleucovorin is indicated for use as rescue therapy following high-dose methotrexate in the treatment of osteosarcoma or for diminishing the toxicity associated with inadvertent overdosage of folic acid antagonists. Levoleucovorin, as the product Fusilev (FDA, dosed at one-half the usual dose of racemic d,l-leucovorin), has an additional indication for use in combination chemotherapy with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer (although they should not be mixed in the same infusion as a precipitate may form). View
FI8DB08874(Fidaxomicin) Treatment of Clostridium difficile-associated diarrhea View
FITDB01216(Finasteride) For the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to: Improve symptoms, reduce the risk of acute urinary retention, reduce the risk of the need for surgery including transurethral resection of the prostate. Also used for the stimulation of regrowth of hair in men with mild to moderate androgenetic alopecia (male pattern alopecia, hereditary alopecia, common male baldness). View
FJQDB01007(Tioconazole) For the local treatment of vulvovaginal candidiasis (moniliasis). View
FK5DB00864(Tacrolimus) For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was first approved by the FDA in 1994 for use in liver transplantation, this has been extended to include kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis. View
FL7DB00690(Flurazepam) For short-term and intermittent use in patients with recurring insomnia and poor sleeping habits View
FLPDB00712(Flurbiprofen) Flurbiprofen tablets are indicated for the acute or long-term symptomatic treatment of rheumatoid arthritis, osteorarthritis and anklosing spondylitis. It may also be used to treat pain associated with dysmenorrhea and mild to moderate pain accompanied by inflammation (e.g. bursitis, tendonitis, soft tissue trauma). Topical ophthalmic formulations may be used pre-operatively to prevent intraoperative miosis. View
FLRDB00712(Flurbiprofen) Flurbiprofen tablets are indicated for the acute or long-term symptomatic treatment of rheumatoid arthritis, osteorarthritis and anklosing spondylitis. It may also be used to treat pain associated with dysmenorrhea and mild to moderate pain accompanied by inflammation (e.g. bursitis, tendonitis, soft tissue trauma). Topical ophthalmic formulations may be used pre-operatively to prevent intraoperative miosis. View
FMMDB01259(Lapatinib) Indicated in combination with capecitabine for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress the human epidermal receptor type 2 (HER2) protein and who have received prior therapy including an anthracycline, a taxane, and trastuzuma. View
FOLDB00158(Folic Acid) For treatment of folic acid deficiency, megaloblastic anemia and in anemias of nutritional supplements, pregnancy, infancy, or childhood. View
FOZDB11596(Levoleucovorin) Levoleucovorin is indicated for use as rescue therapy following high-dose methotrexate in the treatment of osteosarcoma or for diminishing the toxicity associated with inadvertent overdosage of folic acid antagonists. Levoleucovorin, as the product Fusilev (FDA, dosed at one-half the usual dose of racemic d,l-leucovorin), has an additional indication for use in combination chemotherapy with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer (although they should not be mixed in the same infusion as a precipitate may form). View
FRDDB00182(Amphetamine) For treatment of Attention Deficit Disorder with Hyperactivity (ADDH), narcolepsy, and exogenous obesity as a short term (a few weeks) adjunct in a regimen of weight reduction based on caloric restriction for patients refractory to alternative therapy. View
FUADB02703(Fusidic Acid) For the treatment of bacterial infections. View
FUNDB00695(Furosemide) For the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Also for the treatment of hypertension alone or in combination with other antihypertensive agents. View
FVSDB00947(Fulvestrant) For the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. View
FVTDB00855(Aminolevulinic acid) Aminolevulinic acid plus blue light illumination using a blue light photodynamic therapy illuminator is indicated for the treatment of minimally to moderately thick actinic keratoses of the face or scalp. View
FVXDB00176(Fluvoxamine) Indicated predominantly for the management of depression and for Obsessive Compulsive Disorder (OCD) [FDA Label]. Has also been used in the management of bulimia nervosa [A250]. View
FY5DB04574(Estrone sulfate) Estropipate is used for the treatment of moderate to severe vasomotor symptoms associated with the monopause, and moderate to severe symptoms of vulval and vaginal atrophy associated with the menopause. It is also used to treat hypoestrogenism due to hypogonadism, castration or primary ovarian failure, and prevent postmenopausal osteoporosis. View
FYPDB01205(Flumazenil) For the complete or partial reversal of the sedative effects of benzodiazepines in cases where general anesthesia has been induced and/or maintained with benzodiazepines, and where sedation has been produced with benzodiazepines for diagnostic and therapeutic procedures. Also for the management of benzodiazepine overdose as an adjunct for appropriate supportive and symptomatic measures. View
GA2DB01004(Ganciclovir) For induction and maintenance in the treatment of cytomegalovirus (CMV) retinitis in immunocompromised patients, including patients with acquired immunodeficiency syndrome (AIDS). Also used in the treatment of severe cytomegalovirus (CMV) disease, including CMV pneumonia, CMV gastrointestinal disease, and disseminated CMV infections, in immunocompromised patients. View
GAIDB00536(Guanidine) For the reduction of the symptoms of muscle weakness and easy fatigability associated with the myasthenic syndrome of Eaton-Lambert. It is not indicated for treating myasthenia gravis. View
GAWDB09048(Netupitant) Netupitant is an antiemitic drug approved by the FDA in October 2014 for use in combination with palonosetron for the prevention of acute and delayed vomiting and nausea associated with cancer chemotherapy including highly emetogenic chemotherapy. View
GBMDB01016(Glyburide) Indicated as an adjunct to diet to lower the blood glucose in patients with NIDDM whose hyperglycemia cannot be satisfactorily controlled by diet alone. View
GBNDB00996(Gabapentin) For the management of postherpetic neuralgia in adults and as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in patients over 12 years of age with epilepsy. View
GBQDB00673(Aprepitant) For the prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including high-dose cisplatin (in combination with other antiemetic agents). View
GCSDB01296(Glucosamine) Glucosamine is usually used in the treatment of osteoarthritis, although its efficacy is still in question. View
GEODB00441(Gemcitabine) Gemcitabine is indicated for the treatment of advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy; metastatic ovarian cancer; inoperable, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer; and locally advanced (nonresectable Stage II or Stage III) or metastatic (Stage IV) adenocarcinoma of the pancreas. View
GFNDB01044(Gatifloxacin) For the treatment of bronchitis, sinusitis, community-acquired pneumonia, and skin infections (abscesses, wounds) caused by S. pneumoniae, H. influenzae, S. aureus, M. pneumoniae, C. pneumoniae, L. pneumophila, S. pyogenes View
GG2DB06605(Apixaban) Apixaban is to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It has also been used to lower the risk of developing venous thrombosis post-orthopedic surgical procedures. View
GJZDB00752(Tranylcypromine) For the treatment of major depressive episode without melancholia. View
GLYDB00145(Glycine) Supplemental glycine may have antispastic activity. Very early findings suggest it may also have antipsychotic activity as well as antioxidant and anti-inflammatory activities. View
GM4DB00652(Pentazocine) For the relief of moderate to severe pain. View
GMJDB00502(Haloperidol) For the management of psychotic disorders (eg. schizophrenia) and delirium, as well as to control tics and vocal utterances of Tourette's syndrome (Gilles de la Tourette's syndrome). Also used for the treatment of severe behavioural problems in children with disrubtive behaviour disorder or ADHD (attention-deficit hyperactivity disorder). Haloperidol has been used in the prevention and control of severe nausea and vomiting. View
GMRDB00222(Glimepiride) For concomitant use with insulin for the treatment of noninsulin-dependent (type 2) diabetes mellitus. View
GNTDB00674(Galantamine) For the treatment of mild to moderate dementia of the Alzheimer's type. Has also been investigated in patients with mild cognitive impairment who did not meet the diagnostic criteria for Alzheimer's disease. View
GW6DB08906(Fluticasone furoate) Fluticasone furoate nasal spray is indicated for the treatment of the symptoms of seasonal and perennial allergic rhinitis in patients aged 2 years and older. View
H3PDB00756(Hexachlorophene) For use as a surgical scrub and a bacteriostatic skin cleanser. It may also be used to control an outbreak of gram-positive infection where other infection control procedures have been unsuccessful. View
H4BDB00360(Sapropterin) For the treatment of tetrahydrobiopterin (BH4) deficiency. View
H4CDB09166(Etizolam) Etizolam (marketed under the brand name Etilaam, Etizola, Sedekopan, Etizest, Pasaden or Depas) is a benzodiazepine analog. The etizolam molecule differs from a benzodiazepine in that the benzene ring has been replaced by a thiophene ring, making the drug a thienodiazepine. It possesses amnesic, anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties. Etizolam is not authorized for medical use in the U.S. However, it currently remains unscheduled and is legal for research purposes. View
H8DDB00353(Methylergometrine) For the prevention and control of excessive bleeding following vaginal childbirth View
H8GDB00589(Lisuride) For the management of Parkinson's Disease View
H8JDB00247(Methysergide) For the treatment of vascular headache View
H98DB01274(Arformoterol) A bronchodilator used for the long term, symptomatic treatment of reversible bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. View
HAEDB00551(Acetohydroxamic Acid) Used, in addition to antibiotics or medical procedures, to treat chronic urea-splitting urinary infections. View
HCYDB00741(Hydrocortisone) For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Also used to treat endocrine (hormonal) disorders (adrenal insufficiency, Addisons disease). It is also used to treat many immune and allergic disorders, such as arthritis, lupus, severe psoriasis, severe asthma, ulcerative colitis, and Crohn's disease. View
HCZDB00999(Hydrochlorothiazide) For the treatment of high blood pressure and management of edema. View
HFGDB04866(Halofuginone) For the treatment of scleroderma, cancer, and restenosis. View
HFZDB00774(Hydroflumethiazide) Used as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Also used in the management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension. View
HISDB00117(L-Histidine) The actions of supplemental L-histidine are entirely unclear. It may have some immunomodulatory as well as antioxidant activity. L-histidine may be indicated for use in some with rheumatoid arthritis. It is not indicated for treatment of anemia or uremia or for lowering serum cholesterol. View
HLTDB01159(Halothane) For the induction and maintenance of general anesthesia View
HLZDB01275(Hydralazine) For the treatment of essential hypertension, alone or as an adjunct. Also for the management of severe hypertension when the drug cannot be given orally or when blood pressure must be lowered immediately, congestive heart failure (in combination with cardiac glycosides and diuretics and/or with isosorbide dinitrate), and hypertension secondary to pre-eclampsia/eclampsia. View
HNQDB01422(Nitroxoline) Nitroxoline is an antibiotic agent. View
HQEDB09526(Hydroquinone) Hydroquinone is used as an OTC topical lightening agent for disorders of hyperpigmentation including melasma, post-inflammatory hyperpigmention, sunspots and freckles. View
HSMDB05381(Histamine) Histamine phosphate is indicated as a diagnostic aid for evaluation of gastric acid secretory function. View
HU5DB08873(Boceprevir) Boceprevir, when used in combination with [DB00811], [DB00008], and [DB00022] is indicated for use in the treatment of chronic HCV genotype 1 infection in adults [FDA Label]. View
I7ADB01144(Diclofenamide) For adjunctive treatment of: chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure View
IBPDB01050(Ibuprofen) For symptomatic treatment of rheumatoid arthritis, juvenile rheumatoid arthritis and osteoarthritis. May be used to treat mild to moderate pain and for the management of dysmenorrhea. May be used to reduce fever. Has been used with some success for treating ankylosing spondylitis, gout and psoriatic arthritis. May reduce pain, fever and inflammation of pericarditis. May be used IV with opiates to relieve moderate to severe pain. Ibuprofen lysine may be used IV to treat patent ductus arteriosus (PDA) in premature neonates. View
ICFDB00753(Isoflurane) For induction and maintenance of general anesthesia. View
ID2DB00249(Idoxuridine) For use in keratoconjunctivitis and keratitis caused by herpes simplex virus. View
ID8DB00784(Mefenamic acid) For the treatment of rheumatoid arthritis, osteoarthritis, dysmenorrhea, and mild to moderate pain, inflammation, and fever. View
IL2DB01088(Iloprost) Used for the treatment of pulmonary arterial hypertension. View
ILEDB00167(L-Isoleucine) The branched-chain amino acids may have antihepatic encephalopathy activity in some. They may also have anticatabolic and antitardive dyskinesia activity. View
IMNDB00328(Indomethacin) For moderate to severe rheumatoid arthritis including acute flares of chronic disease, ankylosing spondylitis, osteoarthritis, acute painful shoulder (bursitis and/or tendinitis) and acute gouty arthritis. View
IPBDB02513(Thymol) A phenol obtained from thyme oil or other volatile oils. It is used as a stabilizer in pharmaceutic preparations. It has been used for its antiseptic, antibacterial, and antifungal actions, and was formerly used as a vermifuge. (Dorland, 28th ed) View
IPHDB03255(Phenol) Phenol is primarily indicated for minor sore throat pain, sore mouth, minor mouth irritation, and pain associated with canker sores. Additionally, phenol is indicated in the treatment of focal spasticity. View
IREDB00317(Gefitinib) For the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of either platinum-based or docetaxel chemotherapies. View
IU5DB01586(Ursodeoxycholic acid) The drug reduces cholesterol absorption and is used to dissolve (cholesterol) gallstones in patients who want an alternative to surgery. View
IVMDB00602(Ivermectin) A broad-spectrum anti-parasite medication. It was first marketed under the name Stromectol® and used against worms (except tapeworms), but, in 2012, it was approved for the topical treatment of head lice infestations in patients 6 months of age and older, and marketed under the name Sklice™ as well. Ivermectin is mainly used in humans in the treatment of onchocerciasis, but is also effective against other worm infestations (such as strongyloidiasis, ascariasis, trichuriasis and enterobiasis). View
IXXDB00458(Imipramine) For the relief of symptoms of depression and as temporary adjunctive therapy in reducing enuresis in children aged 6 years and older [FDA Label]. View
IZPDB01050(Ibuprofen) For symptomatic treatment of rheumatoid arthritis, juvenile rheumatoid arthritis and osteoarthritis. May be used to treat mild to moderate pain and for the management of dysmenorrhea. May be used to reduce fever. Has been used with some success for treating ankylosing spondylitis, gout and psoriatic arthritis. May reduce pain, fever and inflammation of pericarditis. May be used IV with opiates to relieve moderate to severe pain. Ibuprofen lysine may be used IV to treat patent ductus arteriosus (PDA) in premature neonates. View
J01DB00766(Clavulanate) For use with Amoxicillin, clavulanic acid is suitable for the treatment of infections with <i>Staph. aureus</i> and <i>Bacteroides fragilis</i>, or with beta-lactamase producing <i>H. influenzae</i> and <i>E. coli</i>. View
J3ZDB00655(Estrone) For management of perimenopausal and postmenopausal symptoms. View
JMSDB00939(Meclofenamic acid) For the relief of mild to moderate pain, for the treatment of primary dysmenorrhea and for the treatment of idiopathic heavy menstrual blood loss. Also for relief of the signs and symptoms of acute and chronic rheumatoid arthritis and osteoarthritis. View
JN3DB01586(Ursodeoxycholic acid) The drug reduces cholesterol absorption and is used to dissolve (cholesterol) gallstones in patients who want an alternative to surgery. View
JTZDB00866(Alprenolol) For the treatment of hypertension, angina, and arrhythmia View
K1SDB09283(Trapidil) Used to treat patients with ischemic coronary heart, liver, and kidney disease. View
K4DDB01195(Flecainide) Flecainide is is a class Ic antiarrhythmic agent and as such, it is used for the prevention of paroxysmal supraventricular tachycardias (PSVT), including atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia and other supraventricular tachycardias of unspecified mechanism associated with disablin. View
K5YDB00938(Salmeterol) For the treatment of asthma and chronic obstructive pulmonary disease (COPD). View
K86DB00559(Bosentan) Used in the treatment of pulmonary arterial hypertension (PAH), to improve exercise ability and to decrease the rate of clinical worsening (in patients with WHO Class III or IV symptoms). View
KANDB01172(Kanamycin) For treatment of infections where one or more of the following are the known or suspected pathogens: <i>E. coli</i>, <i>Proteus</i> species (both indole-positive and indole-negative), <i>E. aerogenes, K. pneumoniae, S. marcescens,</i> and <i>Acinetobacter</i> species. View
KKKDB01026(Ketoconazole) For the treatment of the following systemic fungal infections: candidiasis, chronic mucocutaneous candidiasis, oral thrush, candiduria, blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis. View
KLNDB01026(Ketoconazole) For the treatment of the following systemic fungal infections: candidiasis, chronic mucocutaneous candidiasis, oral thrush, candiduria, blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis. View
KLTDB00310(Chlorthalidone) For management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension. View
KOVDB01112(Cefuroxime) For the treatment of many different types of bacterial infections such as bronchitis, sinusitis, tonsillitis, ear infections, skin infections, gonorrhea, and urinary tract infections. View
KTNDB01026(Ketoconazole) For the treatment of the following systemic fungal infections: candidiasis, chronic mucocutaneous candidiasis, oral thrush, candiduria, blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis. View
KTRDB00465(Ketorolac) For the short-term (~5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. View
L8PDB00369(Cidofovir) For the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS) View
LAXDB00154(Dihomo-gamma-linolenic acid) For nutritional supplementation, also for treating dietary shortage or imbalance View
LBHDB06603(Panobinostat) Panobinostat is indicated in the treatment of multiple myeloma in combination with dexamethasone and bortezomib in patients who have received 2 previous treatment regimens including bortezomib and an immunomodulatory agent. This indication is approved by accelerated approval based on progression free survival as of February 23, 2015. View
LCRDB00341(Cetirizine);DB06282(Levocetirizine) For the relief of symptoms associated with seasonal allergic rhinitis, perennial allergic rhinitis and the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria;Levocetirizine is indicated for the relief of symptoms associated with allergic rhinitis (seasonal and perennial) in adults and children 6 years of age and older. View
LDPDB00988(Dopamine) For the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarction, trauma, endotoxic septicemia, open-heart surgery, renal failure, and chronic cardiac decompensation as in congestive failure View
LEIDB00859(Penicillamine) For treatment of Wilson's disease, cystinuria and active rheumatoid arthritis. View
LEUDB00149(L-Leucine) Indicated to assist in the prevention of the breakdown of muscle proteins that sometimes occur after trauma or severe stress. View
LEVDB09078(Lenvatinib) Lenvatinib is indicated for the treatment of patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer. View
LF7DB04876(Vildagliptin) Used to reduce hyperglycemia in type 2 diabetes mellitus. View
LFXDB01137(Levofloxacin);DB01165(Ofloxacin) For the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: <i>Corynebacterium</i> species, <i>Staphylococus aureus</i>, <i>Staphylococcus epidermidis</i>, <i>Streptococcus pneumoniae</i>, <i>Streptococcus</i> (Groups C/F/G), Viridans group streptococci, <i>Acinetobacter lwoffii</i>, <i>Haemophilus influenzae</i>, <i>Serratia marcescens</i>.;For the treatment of infections (respiratory tract, kidney, skin, soft tissue, UTI), urethral and cervical gonorrhoea. View
LLLDB04729(GENTAMICIN C1A) View
LLTDB01265(Telbivudine) For the treatment of chronic hepatitis B in adult and adolescent patients ≥16 years of age with evidence of viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease. View
LNLDB00132(Alpha-Linolenic Acid) For nutritional supplementation and for treating dietary shortage or imbalance. View
LNRDB00368(Norepinephrine) Mainly used to treat patients in vasodilatory shock states such as septic shock and neurogenic shock and has shown a survival benefit over dopamine. Also used as a vasopressor medication for patients with critical hypotension. View
LOCDB01394(Colchicine) For treatment and relief of pain in attacks of acute gouty arthritis. View
LPRDB00722(Lisinopril) For the treatment of hypertension and symptomatic congestive heart failure. May be used in conjunction with thrombolytic agents, aspirin and/or &beta;-blockers to improve survival in hemodynamically stable individuals following myocardial infarction. May be used to slow the progression of renal disease in hypertensive patients with diabetes mellitus and microalbuminuria or overt nephropathy. View
LQQDB09073(Palbociclib) Palbociclib is indicated in combination with letrozole for the treatment of postmenopausal women with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer as initial endocrine-based therapy for their metastatic disease. This indication is approved under accelerated approval based on progression-free survival (PFS). Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. View
LQZDB00281(Lidocaine) For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks. View
LSNDB00678(Losartan) May be used as a first line agent to treat uncomplicated hypertension, isolated systolic hypertension and left ventricular hypertrophy. May be used as a first line agent to delay progression of diabetic nephropathy. Losartan may be also used as a second line agent in the treatment of congestive heart failure, systolic dysfunction, myocardial infarction and coronary artery disease in those intolerant of ACE inhibitors. View
LURDB01283(Lumiracoxib) For the acute and chronic treatment of the signs and symptoms of osteoarthritis of the knee in adults. View
LVYDB00480(Lenalidomide) Lenalidomide is indicated for the treatment of multiple myeloma in combination with dexamethasone. It is also indicated for the treatment of patients with transfusion-dependent anemia due to low- or intermediate- risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. View
LYADB00642(Pemetrexed) Used in combination with cisplatin for the treatment of malignant pleural mesothelioma in adults whose disease is unresectable or who otherwise are not candidates for potentially curative surgery. Also used as a monotherapy for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) after prior chemotherapy View
LZUDB00679(Thioridazine) For the treatment of schizophrenia and generalized anxiety disorder. View
MC9DB02300(Calcipotriol) For the treatment of moderate plaque psoriasis in adults. View
MEMDB00760(Meropenem) For use as single agent therapy for the treatment of the following infections when caused by susceptible isolates of the designated microorganisms: <b>complicated skin and skin structure infections</b> due to <i>Staphylococcus aureus</i> (b-lactamase and non-b-lactamase producing, methicillin-susceptible isolates only), <i>Streptococcus pyogenes</i>, <i>Streptococcus agalactiae</i>, viridans group streptococci, <i>Enterococcus faecalis</i> (excluding vancomycin-resistant isolates), <i>Pseudomonas aeruginosa</i>, <i>Escherichia coli</i>, <i>Proteus mirabilis</i>, <i>Bacteroides fragilis</i> and <i>Peptostreptococcus</i> species; <b>complicated appendicitis and peritonitis</b> caused by viridans group streptococci, <i>Escherichia coli</i>, <i>Klebsiella pneumoniae</i>, <i>Pseudomonas aeruginosa</i>, <i>Bacteroides fragilis</i>, <i>B. thetaiotaomicron</i>, and <i>Peptostreptococcus</i> species. Also for use in the treatment of bacterial meningitis caused by <i>Streptococcus pneumoniae</i>, <i>Haemophilus influenzae</i> (b-lactamase and non-b-lactamase-producing isolates), and <i>Neisseria meningitidis</i>. View
MF8DB00331(Metformin) For use as an adjunct to diet and exercise in adult patients (18 years and older) with NIDDM. May also be used for the management of metabolic and reproductive abnormalities associated with polycystic ovary syndrome (PCOS). Jentadueto is for the treatment of patients when both linagliptin and metformin is appropriate. View
MFXDB00218(Moxifloxacin) For the treatment of sinus and lung infections such as sinusitis, pneumonia, and secondary infections in chronic bronchitis. Also for the treatment of bacterial conjunctivitis (pinkeye). View
MI1DB08895(Tofacitinib) For the treatment of moderate to severe rheumatoid arthritis which is resistant or intolerant to methotrexate therapy. It may also be used as an adjunct to methotrexate therapy, or other non-biologic disease-modifying antirheumatic drugs (DMARDS), when methotrexate alone is not sufficient. View
MIGDB00491(Miglitol) For use as an adjunct to diet to improve glycemic control in patients with non-insulin-dependent diabetes mellitus (NIDDM) whose hyperglycemia cannot be managed with diet alone. View
MIIDB01603(Meticillin) Used to treat infections caused by susceptible Gram-positive bacteria, particularly beta-lactamase-producing organisms such as <i>Staphylococcus aureus</i> that would otherwise be resistant to most penicillins. View
MILDB00235(Milrinone) Indicated for the treatment of congestive heart failure. View
MITDB00278(Argatroban) Argatroban is indicated for prevention and treatment of thrombosis caused by heparin induced thrombocytopenia (HIT). It is also indicated for use in patients with, or at risk for, HIT who are undergoing percutaneous coronary intervention. View
MIXDB01204(Mitoxantrone) For the treatment of secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis View
MIYDB01017(Minocycline) For the treatment of infections caused by susceptible strains of microorganisms, such as Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsial pox and tick fevers caused by Rickettsiae, upper respiratory tract infections caused by <i>Streptococcus pneumoniae</i> and for the treatment of asymptomatic carriers of <i>Neisseria meningitidis</i>. View
MK1DB00224(Indinavir) Indinavir is an antiretroviral drug for the treatment of HIV infection. View
ML1DB01065(Melatonin) Used orally for jet lag, insomnia, shift-work disorder, circadian rhythm disorders in the blind (evidence for efficacy), and benzodiazepine and nicotine withdrawal. Evidence indicates that melatonin is likely effective for treating circadian rhythm sleep disorders in blind children and adults. It has received FDA orphan drug status as an oral medication for this use. A number of studies have shown that melatonin may be effective for treating sleep-wake cycle disturbances in children and adolescents with mental retardation, autism, and other central nervous system disorders. It appears to decrease the time to fall asleep in children with developmental disabilities, such as cerebral palsy, autism, and mental retardation. It may also improve secondary insomnia associated with various sleep-wake cycle disturbances. Other possible uses for which there is some evidence for include: benzodiazepine withdrawal, cluster headache, delayed sleep phase syndrome (DSPS), primary insomnia, jet lag, nicotine withdrawal, preoperative anxiety and sedation, prostate cancer, solid tumors (when combined with IL-2 therapy in certain cancers), sunburn prevention (topical use), tardive dyskinesia, thrombocytopenia associated with cancer, chemotherapy and other disorders. View
MMSDB01055(Mimosine) View
MMZDB00763(Methimazole) For the treatment of hyperthyroidism, goiter, Graves disease and psoriasis. View
MN9DB00141(N-Acetyl-D-glucosamine) For the treatment and prevention of osteoarthritis, by itself or in combination with chondroitin sulfate. View
MOADB01024(Mycophenolic acid) For the prophylaxis of organ rejection in patients receiving allogeneic renal transplants, administered in combination with cyclosporine and corticosteroids. View
MOIDB00295(Morphine) For the relief and treatment of severe pain. View
MRCDB00410(Mupirocin) For the treatment of <i>Staphylococci</i> nasal carriers. View
MRVDB04835(Maraviroc) For treatment-experienced adult patients infected with only CCR5-tropic HIV-1 detectable, who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents. View
MTKDB00471(Montelukast) For the treatment of asthma View
MTLDB00742(Mannitol) Used for the promotion of diuresis before irreversible renal failure becomes established, the reduction of intracranial pressure, the treatment of cerebral edema, and the promotion of urinary excretion of toxic substances. View
MTXDB00563(Methotrexate) Methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. In acute lymphocytic leukemia, methotrexate is indicated in the prophylaxis of meningeal leukemia and is used in maintenance therapy in combination with other chemotherapeutic agents. Methotrexate is also indicated in the treatment of meningeal leukemia. Methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous T cell lymphoma), and lung cancer, particularly squamous cell and small cell types. Methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non-Hodgkin’s lymphomas. Methotrexate is indicated in the symptomatic control of severe, recalcitrant, disabling psoriasis. Methotrexate is indicated in the management of selected adults with severe, active rheumatoid arthritis (ACR criteria), or children with active polyarticular-course juvenile rheumatoid arthritis. View
MV2DB09357(Dexpanthenol) Injection: Prophylactic use immediately after major abdominal surgery to minimize the possibility of paralytic ileus. Intestinal atony causing abdominal distention; postoperative or postpartum retention of flatus, or postoperative delay in resumption of intestinal motility; paralytic ileus. View
MXDDB00350(Minoxidil) For the treatment of severe hypertension and in the topical treatment (regrowth) of androgenic alopecia in males and females and stabilisation of hair loss in patients with androgenic alopecia. View
MXMDB00814(Meloxicam) For symptomatic treatment of arthritis and osteoarthritis. View
MYTDB01011(Metyrapone) Used as a diagnostic drug for testing hypothalamic-pituitary ACTH function. Occasionally used in Cushing's syndrome. View
MZMDB00703(Methazolamide) For treatment of chronic open-angle glaucoma and acute angle-closure glaucoma View
NBODB00461(Nabumetone) For acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthritis. View
NBVDB00419(Miglustat) For the treatment of adult patients with mild to moderate type 1 (nonneuropathic) Gaucher's disease for whom enzyme replacement therapy is not a therapeutic option (e.g. due to constraints such as allergy, hypersensitivity, or poor venous access). Now approved in some countries for the treatment of progressive neurological symptoms in adult and pediatric patients with Niemann-Pick disease type C (NP-C). View
NCADB02701(Nicotinamide) An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and pellagra. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake. [PubChem] View
NCTDB00184(Nicotine) For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation. View
NDRDB00717(Norethisterone) For the treatment of secondary amenorrhea, endometriosis, and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer. View
NFLDB04552(Niflumic Acid) Used in the treatment of rheumatoid arthritis. View
NFNDB00607(Nafcillin) Indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. View
NFZDB00336(Nitrofural) For the treatement of bacterial skin infections including pyodermas, infected dermatoses and infections of cuts, wounds, burns and ulcers due to susceptible organisms. View
NHYDB01005(Hydroxyurea) For management of melanoma, resistant chronic myelocytic leukemia, and recurrent, metastatic, or inoperable carcinoma of the ovary and Sickle-cell anemia. View
NILDB04868(Nilotinib) For the potential treatment of various leukemias, including chronic myeloid leukemia (CML). View
NIMDB04743(Nimesulide) For the treatment of acute pain, the symptomatic treatment of osteoarthritis and primary dysmenorrhoea in adolescents and adults above 12 years old. View
NIODB00627(Niacin) For the treatment of type IV and V hyperlipidemia. It is indicated as ajunctive therapy. View
NIZDB00951(Isoniazid) For the treatment of all forms of tuberculosis in which organisms are susceptible. View
NMYDB00452(Framycetin);DB00994(Neomycin) For the treatment of bacterial blepharitis, bacterial bonjunctivitis, corneal injuries, corneal ulcers and meibomianitis. For the prophylaxis of ocular infections following foreign body removal;Topical uses include treatment for superficial eye infections caused by susceptible bacteria (used in combination with other antiinfectives), treatment of otitis externa caused by susceptible bacteria, treatment or prevention of bacterial infections in skin lesions, and use as a continuous short-term irrigant or rinse to prevent bacteriuria and gram negative rod bacteremia in abacteriuric patients with indwelling catheters. May be used orally to treat hepatic encephalopathy, as a perioperative prophylactic agent, and as an adjunct to fluid and electrolyte replacement in the treatment of diarrhea caused to enteropathogenic E. coli (EPEC). View
NOGDB00367(Levonorgestrel);DB09389(Norgestrel) For the treatment of menopausal and postmenopausal disorders and alone or in combination with other hormones as an oral contraceptive.;Norgestrel in combination with ethinyl estradiol is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. View
NOVDB01051(Novobiocin) For the treatment of infections due to staphylococci and other susceptible organisms View
NPSDB00788(Naproxen) For the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis, and acute gout. Also for the relief of mild to moderate pain and the treatment of primary dysmenorrhea. View
NPUDB00397(Phenylpropanolamine) For the treatment of nasal congestion, control of urinary incontinence, priapism and obesity. View
NTIDB00507(Nitazoxanide) For the treatment of diarrhea in adults and children caused by the protozoa <i>Giardia lamblia</i>, and for the treatment of diarrhea in children caused by the protozoan, <i>Cryptosporidium parvum</i> [FDA label]. View
NVPDB00238(Nevirapine) For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection. View
OAQDB01096(Oxamniquine) For treatment of Schistosomiasis caused by <i>Schistosoma mansoni</i> View
OBNDB01092(Ouabain) For the treatment of atrial fibrillation and flutter and heart failure View
OHBDB08797(Salicylamide) Salicylamide is the common name for the substance o-hydroxybenzamide, or amide of salicyl. Salicylamide is a non-prescription drug with analgesic and antipyretic properties. Its medicinal uses are similar to those of aspirin. Salicylamide is used in combination with both aspirin and caffeine in the over-the-counter pain remedies View
OINDB00424(Hyoscyamine);DB00572(Atropine) For treatment of bladder spasms, peptic ulcer disease, diverticulitis, colic, irritable bowel syndrome, cystitis, and pancreatitis. Also used to treat certain heart conditions, to control the symptoms of Parkinson's disease and rhinitis.;For the treatment of poisoning by susceptible organophosphorous nerve agents having anti-cholinesterase activity (cholinesterase inhibitors) as well as organophosphorous or carbamate insecticides. View
OLMDB00275(Olmesartan) For the treatment of hypertension. View
OQRDB01096(Oxamniquine) For treatment of Schistosomiasis caused by <i>Schistosoma mansoni</i> View
OTCDB00595(Oxytetracycline) Oxytetracycline is indicated for treatment of infections caused by a variety of Gram positive and Gram negative microorganisms including <i>Mycoplasma pneumoniae, Pasteurella pestis, Escherichia coli, Haemophilus influenzae</i> (respiratory infections), and <i>Diplococcus pneumoniae</i>. View
P06DB08912(Dabrafenib) Tafinlar is a kinase inhibitor that was initially indicated as a single agent for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved test [FDA label]. View
P1BDB01132(Pioglitazone) Pioglitazone is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [FDA Label]. View
P1ZDB00812(Phenylbutazone) For the treatment of backache and ankylosing spondylitis View
P2EDB00917(Dinoprostone) For the termination of pregnancy during the second trimester (from the 12th through the 20th gestational week as calculated from the first day of the last normal menstrual period), as well as for evacuation of the uterine contents in the management of missed abortion or intrauterine fetal death up to 28 weeks of gestational age as calculated from the first day of the last normal menstrual period. Also used in the management of nonmetastatic gestational trophoblastic disease (benign hydatidiform mole). Other indications include improving the cervical inducibility (cervical "ripening") in pregnant women at or near term with a medical or obstetrical need for labor induction, and the management of postpartum hemorrhage. View
P2ZDB00420(Promazine) Used as an adjunct for short term treatment of moderate and severe psychomotor agitation. Also used to treat agitation or restlessness in the elderly. View
P77DB00433(Prochlorperazine) For the symptomatic management of psychotic disorders, short term management of nonpsychotic anxiety in patients with generalized anxiety disorder, and for the control of severe nausea and vomiting of various causes. View
PA1DB01296(Glucosamine) Glucosamine is usually used in the treatment of osteoarthritis, although its efficacy is still in question. View
PACDB09269(Phenylacetic acid) For use as adjunctive therapy for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle. View
PARDB01421(Paromomycin) For the treatment of acute and chronic intestinal amebiasis (it is not effective in extraintestinal amebiasis). Also for the management of hepatic coma as adjunctive therapy. View
PAUDB01783(Pantothenic acid) Studied for the treatment of many uses such as treatment of testicular torsion, diabetic ulceration, wound healing, acne, obesity, diabetic peripheral polyneuropathy. It has also been investigated for its hypolipidemic effects and as cholesterol lowering agent. View
PCFDB09114(Colfosceril palmitate) Colfosceril palmitate is a drug used as a pulmonary surfactant. It is a drug that is used in surfactant deficient conditions such as IRDS in newborns. View
PE2DB00299(Penciclovir) Used to treat recurrent cold sores on the lips and face from various herpesvirus invections. View
PEMDB01393(Bezafibrate) For the treatment of primary hyperlipidaemia types IIa, IIb, III, IV and V (Fredrickson classification) corresponding to groups I, II and III of the European Atherosclerosis Society guidelines - when diet alone or improvements in lifestyle such as increased exercise or weight reduction do not lead to an adequate response. Also for the treatment of secondary hyperlipidaemias, e.g. severe hypertriglyceridemias, when sufficient improvement does not occur after correction of the underlying disorder (e.g. diabetes mellitus). View
PFLDB00818(Propofol) Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus. View
PFNDB00573(Fenoprofen) For relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. Also for the relief of mild to moderate pain. View
PM6DB01033(Mercaptopurine) For remission induction and maintenance therapy of acute lymphatic leukemia. View
PNNDB01053(Benzylpenicillin) For use in the treatment of severe infections caused by penicillin G-susceptible microorganisms when rapid and high penicillin levels are required such as in the treatment of septicemia, meningitis, pericarditis, endocarditis and severe pneumonia. View
PNTDB00738(Pentamidine) For the treatment of pneumonia due to <i>Pneumocystis carinii</i>. View
PNVDB00417(Phenoxymethylpenicillin) For the treatment of mild to moderately severe infections (e.g. dental infection, infections in the heart, middle ear infections, rheumatic fever, scarlet fever, skin infections, upper and lower respiratory tract infections) due to microorganisms. View
PNXDB00806(Pentoxifylline) For the treatment of patients with intermittent lameness or immobility arising from chronic occlusive arterial disease of the limbs. View
PODDB01179(Podofilox) For treatment of external genital warts (<i>Condyloma acuminatum</i>). View
PPFDB00529(Foscarnet) For the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS) and for treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromised patients. View
PQNDB01022(Phylloquinone) For the treatment of haemorrhagic conditions in infants, antidote for coumarin anticoagulants in hypoprothrombinaemia. View
PRLDB01123(Proflavine) Topical antiseptic used mainly in wound dressings. View
PX9DB09345(Pramocaine) It is indicated for temporary relief of pain and pruritus from minor lip and skin irritations as well as for temporary relief from pain, burning, itching and discomfort associated with hemorrhoids and other anorectal/anogenital disorders. View
PXBDB08439(Parecoxib) Used for short term perioperative pain control. View
PXLDB00147(Pyridoxal) Pyridoxal is one of the natural forms available of vitamin B6, therefore, it is used for nutritional supplementation and for treating dietary shortage or imbalances. View
PZADB00339(Pyrazinamide) For the initial treatment of active tuberculosis in adults and children when combined with other antituberculous agents. View
PZEDB00592(Piperazine) Used as alternative treatment for ascariasis caused by <i>Ascaris lumbricoides</i> (roundworm) and enterobiasis (oxyuriasis) caused by <i>Enterobius vermicularis</i> (pinworm). It is also used to treat partial intestinal obstruction by the common roundworm, a condition primarily occurring in children. View
PZIDB09210(Piracetam) For the treatment of myoclonus (brief, involuntary twitching of a muscle or a group of muscles). View
PZQDB01058(Praziquantel) For the treatment of infections due to all species of schistosoma. View
QDNDB00908(Quinidine) For the treatment of ventricular pre-excitation and cardiac dysrhythmias View
QELDB08954(Ifenprodil) View
QI9DB00468(Quinine) For the treatment of malaria and leg cramps View
QMRDB01273(Varenicline) For use as an aid in smoking cessation. View
QPSDB00284(Acarbose) For treatment and management of diabetes type II (used in combination therapy as a second or third line agent) View
QUNDB01103(Quinacrine) For the treatment of giardiasis and cutaneous leishmaniasis and the management of malignant effusions. View
RABDB00194(Vidarabine) For treatment of chickenpox - varicella, herpes zoster and herpes simplex View
RALDB00481(Raloxifene) For the prevention and treatment of osteoporosis in post-menopausal women, as well as prevention and treatment of corticosteroid-induced bone loss. Also for the reduction in the incidence of invasive breast cancer in postmenopausal women with osteoporosis or have a high risk for developing breast cancer. View
RAPDB00877(Sirolimus) For the prophylaxis of organ rejection in patients receiving renal transplants. View
RAUDB01367(Rasagiline) For the treatment of the signs and symptoms of idiopathic Parkinsons disease as initial monotherapy and as adjunct therapy to levodopa. View
RAVDB00312(Pentobarbital) For the short-term treatment of insomnia. View
RBFDB00140(Riboflavin) For the treatment of ariboflavinosis (vitamin B2 deficiency). View
RBTDB00615(Rifabutin) For the prevention of disseminated <i>Mycobacterium avium</i> complex (MAC) disease in patients with advanced HIV infection. View
RBVDB00811(Ribavirin) Indicated for the treatment of chronic Hepatitis C virus (HCV) infection in combination with other antiviral agents with the intent to cure or achieve a sustained virologic response (SVR). Typically added to improve SVR and reduce relapse rates [A19644]. View
RCXDB00533(Rofecoxib) For the treatment of osteoarthritis, rheumatoid arthritis, acute pain in adults, and primary dysmenorrhea, as well as acute treatment of migraine attacks with or without auras. View
READB00755(Tretinoin) For the the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant); For the topical treatment of acne vulgaris, flat warts and other skin conditions (psoriasis, ichthyosis congenita, icthyosis vulgaris, lamellar icthyosis, keratosis palmaris et plantaris, epidermolytic hyperkeratosis, senile comedones, senile keratosis, keratosis follicularis (Darier's disease), and basal cell carcinomas.); For palliative therapy to improve fine wrinkling, mottled hyperpigmentation, roughness associated with photodamage. View
REMDB00212(Remikiren) For the treatment of hypertension and heart failure View
RFPDB01045(Rifampicin) For the treatment of Tuberculosis and Tuberculosis-related mycobacterial infections. View
RFXDB00472(Fluoxetine) Labeled indication include: major depressive disorder (MDD), moderate to severe bulimia nervosa, obsessive-compulsive disorder (OCD), premenstrual dysphoric disorder (PMDD), panic disorder with or without agoraphobia, and combination treatment with olanzapine for treatment-resistant or bipolar I depression. Unlabeled indications include: selective mutism, mild dementia-associated agitation in nonpsychotic patients, post-traumatic stress disorder (PTSD), social anxiety disorder, chronic neuropathic pain, fibromyalgia, and Raynaud's phenomenon. View
RGZDB00412(Rosiglitazone) Rosiglitazone is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. View
RIMDB00478(Rimantadine) For the prophylaxis and treatment of illness caused by various strains of influenza A virus in adults. View
RIODB03615(Ribostamycin) A broad-spectrum antimicrobial isolated from <i>Streptomyces ribosifidicus</i>. Ribostamycin, along with other aminoglycosides with the DOS (2-deoxystreptamine) subunit, is an important broad-spectrum antibiotic with important use against human immunodeficiency virus and is considered a critically important antimicrobial by the World Health Organization. View
RISDB00884(Risedronate) For the treatment of Paget's disease of the bone (osteitis deformans), postmenopausal and glucocorticoid-induced osteoporosis View
RITDB00503(Ritonavir) Indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. View
RIVDB06228(Rivaroxaban) Rivaroxaban is indicated for the prevention of venous thromboembolic events (VTE) in patients who have undergone total hips replacements and total knee replacement surgery; prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation; treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE); to reduce risk of recurrent DVT and/or PE. Due to a lack of safety studies, it is not recommended for use in those under 18 years old. Its use is also not recommended in those with severe renal impairment (<30mL/min). View
RKEDB01221(Ketamine) Ketamine is indicated as an anesthetic agent for recommended diagnostic and surgical procedures. If skeletal muscle relaxation is needed, it should be combined with a muscle relaxant. If the surgical procedure involves visceral pain, it should be supplemented with an agent that obtunds visceral pain. Ketamine can be used for induction of anesthesia prior other general anesthetic agents and as a supplement of low potency agents.[L1336, FDA label] View
RLTDB06817(Raltegravir) For the treatment of HIV-1 infection in conjunction with other antiretrovirals. View
RO7DB08915(Aleglitazar) Investigated for use in patients with type II diabetes to reduce their risks of cardiovascular mortality and morbidity. View
ROCDB01232(Saquinavir) For the treatment of HIV-1 with advanced immunodeficiency together with antiretroviral nucleoside analogues. View
ROFDB01656(Roflumilast) Roflumilast is indicated as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations. Roflumilast is not a bronchodilator and is not indicated for the relief of acute bronchospasm. View
RPBDB12332(Rucaparib) Indicated as monotherapy for the treatment of patients with deleterious BRCA mutation (germline and/or somatic) associated advanced ovarian cancer who have been treated with two or more chemotherapies. Select patients for therapy based on an FDA-approved companion diagnostic for rucaparib. View
RPTDB01201(Rifapentine) For the treatment of pulmonary tuberculosis. View
RTLDB00162(Vitamin A) For the treatment of vitamin A deficiency. View
RTZDB00679(Thioridazine) For the treatment of schizophrenia and generalized anxiety disorder. View
RWFDB00682(Warfarin) For the treatment of retinal vascular occlusion, pulmonary embolism, cardiomyopathy, atrial fibrillation and flutter, cerebral embolism, transient cerebral ischaemia, arterial embolism and thrombosis. View
RXMDB01220(Rifaximin) Rifaximin has multiple indications by the FDA: for the treatment of patients (≥12 years of age) with traveller's diarrhea caused by noninvasive strains of Escherichia coli; for the reduction of overt hepatic encephalopathy recurrence in patients ≥18 years of age; and in May 2015 it was approved for irritable bowel syndrome with diarrhea (IBS-D) treatment in adult men and women. View
RXTDB08877(Ruxolitinib) Treatment of intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera (post-PV) myelofibrosis and post-essential thrombocythemia (post-ET) myelofibrosis. [Lexicomp] Myeolofibrosis is the proliferation of abnormal bone marrow stem cells which cause fibrosis (the excessive formation of connective tissue). View
RZXDB01129(Rabeprazole) For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, H. pylori eradication, and prevention of gastroinetestinal bleeds with NSAID use. View
SALDB00936(Salicylic acid) Key additive in many skin-care products for the treatment of acne, psoriasis, callouses, corns, keratosis pilaris and warts. View
SAMDB00118(S-Adenosylmethionine) S-Adenosylmethionine (SAMe) is used as a drug in Europe for the treatment of depression, liver disorders, fibromyalgia, and osteoarthritis. It has also been introduced into the United States market as a dietary supplement for the support of bone and joint health, as well as mood and emotional well being. View
SANDB00259(Sulfanilamide) For the treatment of vulvovaginitis caused by <i>Candida albicans</i>. View
SASDB00795(Sulfasalazine) For the treatment of Crohn's disease and rheumatoid arthritis as a second-line agent. View
SC2DB06151(Acetylcysteine) Acetylcysteine is used mainly as a mucolytic and in the management of paracetamol (acetaminophen) overdose. View
SCKDB00202(Succinylcholine) Used in surgical procedures where a rapid onset and brief duration of muscle relaxation is needed (includes intubation, endoscopies, and ECT) View
SFXDB00472(Fluoxetine) Labeled indication include: major depressive disorder (MDD), moderate to severe bulimia nervosa, obsessive-compulsive disorder (OCD), premenstrual dysphoric disorder (PMDD), panic disorder with or without agoraphobia, and combination treatment with olanzapine for treatment-resistant or bipolar I depression. Unlabeled indications include: selective mutism, mild dementia-associated agitation in nonpsychotic patients, post-traumatic stress disorder (PTSD), social anxiety disorder, chronic neuropathic pain, fibromyalgia, and Raynaud's phenomenon. View
SFYDB00891(Sulfapyridine) For the treatment of dermatitis herpetiformis, benign mucous membrane pemphigoid and pyoderma gangrenosum View
SHHDB02546(Vorinostat) For the treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma who have progressive, persistent or recurrent disease on or following two systemic therapies. View
SMXDB01326(Cefamandole) For the treatment of serious infections caused by susceptible strains of microorganisms. View
SNLDB00421(Spironolactone) Used primarily to treat low-renin hypertension, hypokalemia, and Conn's syndrome. View
SNPDB00571(Propranolol) For the prophylaxis of migraine. View
SORDB01638(Sorbitol) Used as a non-stimulant laxative via an oral suspension or enema. View
SPMDB00127(Spermine) For nutritional supplementation, also for treating dietary shortage or imbalance View
SPPDB00705(Delavirdine) For the treatment of HIV-1 infection in combination with appropriate antiretroviral agents when therapy is warranted View
SPRDB06145(Spiramycin) Macrolide antibiotic for treatment of various infections. View
SREDB01104(Sertraline) For the management of major depressive disorder (MDD), posttraumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), panic disorder (PD) with or without agoraphobia, premenstrual dysphoric disorder (PMDD), and social anxiety disorder (SAD) [FDA Label]. View
SRYDB01082(Streptomycin) For the treatment of tuberculosis. May also be used in combination with other drugs to treat tularemia (Francisella tularensis), plague (Yersia pestis), severe M. avium complex, brucellosis, and enterococcal endocarditis (e.g. E. faecalis, E. faecium). View
STIDB00619(Imatinib) For the treatment of Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML), Ph+ acute lymphoblastic leukaemia, myelodysplastic/myeloproliferative diseases, aggressive systemic mastocytosis, hypereosinophilic syndrome and/or chronic eosinophilic leukemia (CEL), dermatofibrosarcoma protuberans, and malignant gastrointestinal stromal tumors (GIST). View
STRDB00396(Progesterone) For progesterone supplementation or replacement as part of an Assisted Reproductive Technology (ART) treatment for infertile women with progesterone deficiency and for the treatment of secondary amenorrhea. Also used for the reduction of the incidence of endometrial hyperplasia and the attendant risk of endometrial carcinoma in postmenopausal women receiving estrogen replacement therapy, as well as treatment of abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology such as fibroids or uterine cancer. View
STZDB00428(Streptozocin) For the treatment of malignant neoplasms of pancreas (metastatic islet cell carcinoma). View
SUEDB11575(Grazoprevir) Grazoprevir is indicated in combination with [DB11574] (as the fixed dose combination product Zepatier) with or without [DB00811] for treatment of chronic HCV genotypes 1a, 1b, or 4 infection in adults. View
SUVDB09034(Suvorexant) Suvorexant is indicated for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance. View
SUZDB00605(Sulindac) For acute or long-term use in the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute painful shoulder (acute subacromial bursitis/supraspinatus tendinitis), and acute gouty arthritis. View
SVRDB04786(Suramin) For treatment of human sleeping sickness, onchocerciasis and other diseases caused by trypanosomes and worms. View
SWFDB00682(Warfarin) For the treatment of retinal vascular occlusion, pulmonary embolism, cardiomyopathy, atrial fibrillation and flutter, cerebral embolism, transient cerebral ischaemia, arterial embolism and thrombosis. View
T0RDB00539(Toremifene) For the treatment of metastatic breast cancer in postmenopausal women with estrogen receptor-positive or receptor-unknown tumors. Toremifene is currently under investigation as a preventative agent for prostate cancer in men with high-grade prostatic intraepithelial neoplasia and no evidence of prostate cancer. View
T1CDB00560(Tigecycline) For the treatment of infections caused by susceptible strains of the designated microorganisms in the following conditions: Complicated skin and skin structure infections caused by <i>Escherichia coli</i>, <i>Enterococcus faecalis</i> (vancomycin-susceptible isolates only), <i>Staphylococcus aureus</i> (methicillin-susceptible and -resistant isolates), <i>Streptococcus agalactiae</i>, <i>Streptococcus anginosus</i> grp. (includes <i>S. anginosus</i>, <i>S. intermedius</i>, and <i>S. constellatus</i>), <i>Streptococcus pyogenes</i> and <i>Bacteroides fragilis</i>. Complicated intra-abdominal infections caused by <i>Citrobacter freundii</i>, <i>Enterobacter cloacae</i>, <i>Escherichia coli</i>, <i>Klebsiella oxytoca</i>, <i>Klebsiella pneumoniae</i>, <i>Enterococcus faecalis</i> (vancomycin-susceptible isolates only), <i>Staphylococcus aureus</i> (methicillin-susceptible isolates only), <i>Streptococcus anginosus</i> grp. (includes <i>S. anginosus</i>, <i>S. intermedius</i>, and <i>S. constellatus</i>), <i>Bacteroides fragilis</i>, <i>Bacteroides thetaiotaomicron</i>, <i>Bacteroides uniformis</i>, <i>Bacteroides vulgatus</i>, <i>Clostridium perfringens</i>, and <i>Peptostreptococcus micros</i>. View
T22DB06203(Alogliptin) Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. View
T27DB08864(Rilpivirine) Rilpivirine, in combination with other agents, is indicated for the treatment of HIV-1 infections in antiretroviral treatment-naive patients with HIV-1 RNA ≤100,000 copies/mL and CD4+ cell count >200 cells/mm3.[L1030] The FDA combination therapy approval of rilpivirine and dolutegravir is indicated for adults with HIV-1 infections whose virus is currently suppressed (< 50 copies/ml) on a stable regimen for at least six months, without history of treatment failure and no known substitutions associated to resistance to any of the two components of the therapy.[L1031] View
T44DB00451(Levothyroxine);DB00509(Dextrothyroxine) For use alone or in combination with antithyroid agents to treat hypothyroidism, goiter, chronic lymphocytic thyroiditis, myxedema coma, and stupor.;Used to lower high cholesterol levels in the blood. View
T98DB04787(Tanaproget) View
TA1DB01229(Paclitaxel) Used in the treatment of Kaposi's sarcoma and cancer of the lung, ovarian, and breast. Abraxane® is specfically indicated for the treatment of metastatic breast cancer and locally advanced or metastatic non-small cell lung cancer. View
TACDB00759(Tetracycline) Used to treat bacterial infections such as Rocky Mountain spotted fever, typhus fever, tick fevers, Q fever, rickettsialpox and Brill-Zinsser disease. May be used to treat infections caused by Chlamydiae spp., B. burgdorferi (Lyme disease), and upper respiratory infections caused by typical (S. pneumoniae, H. influenzae, and M. catarrhalis) and atypical organisms (C. pneumoniae, M. pneumoniae, L. pneumophila). May also be used to treat acne. Tetracycline may be an alternative drug for people who are allergic to penicillin. View
TAZDB01606(Tazobactam) Used in combination with piperacillin to broaden the spectrum of piperacillin antibacterial action. View
TC9DB01199(Tubocurarine) Used as a diagnosis agent for myasthenia gravis, and also to facilitate the intubation after induction of anesthesia in surgical procedure View
TCIDB00470(Dronabinol) For the treatment of anorexia associated with weight loss in patients with AIDS, and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments View
TCWDB00323(Tolcapone) Used as an adjunct to levodopa/carbidopa therapy for the symptomatic treatment of Parkinson's Disease. This drug is generally reserved for patients with parkinsonian syndrome receiving levodopa/carbidopa who are experiencing symptom fluctuations and are not responding adequately to or are not candidates for other adjunctive therapies. View
TDZDB00197(Troglitazone) For the treatment of Type II diabetes mellitus. It is used alone or in combination with a sulfonylurea, metformin, or insulin as an adjunct to diet and exercise. View
TE4DB09085(Tetracaine) The combination lidocaine and tetracaine patch is indicated for local dermal analgesia for superficial dermatological procedures and superficial venous access. The combination lidocaine and tetracaine cream is intended to provide topical local analgesia for superficial dermatological procedures. View
TEIDB04854(Febuxostat) For the treatment of hyperuricemia in patients with gout. View
TEPDB00277(Theophylline) For the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, such as emphysema and chronic bronchitis. View
TESDB00624(Testosterone) To be used as hormone replacement or substitution of diminished or absent endogenous testosterone. Use in males: For management of congenital or acquired hypogonadism, hypogonadism associated with HIV infection, and male climacteric (andopause). Use in females: For palliative treatment of androgen-responsive, advanced, inoperable, metastatis (skeletal) carcinoma of the breast in women who are 1-5 years postmenopausal; testosterone esters may be used in combination with estrogens in the management of moderate to severe vasomotor symptoms associated with menopause in women who do not respond to adequately to estrogen therapy alone. View
TF4DB08809(Dichloroacetic Acid) View
TFODB00300(Tenofovir) View
TFPDB00831(Trifluoperazine) For the treatment of anxiety disorders, depressive symptoms secondary to anxiety and agitation. View
THADB00382(Tacrine) For the palliative treatment of mild to moderate dementia of the Alzheimer's type. View
THHDB11256(Levomefolic acid) Treatment and prevention of folate deficiency Antidote against folic acid antagonists View
THRDB00156(L-Threonine) L-Threonine makes up collagen, elastin, and enamel protein. It aids proper fat metabolism in the liver, helps the digestive and intestinal tracts function more smoothly, and assists in metabolism and assimilation. View
TICDB00208(Ticlopidine) Used in patients, who have had a stroke or stroke precursors and who cannot take aspirin or aspirin has not worked, to try to prevent another thrombotic stroke. View
TIMDB00373(Timolol) In its oral form it is used to treat high blood pressure and prevent heart attacks, and occasionally to prevent migraine headaches. In its opthalmic form it is used to treat open-angle and occasionally secondary glaucoma. View
TIQDB08816(Ticagrelor) For the prevention of thrombotic events (for example stroke or heart attack) in patients with acute coronary syndrome or myocardial infarction with ST elevation. View
TKTDB11699(Tropisetron) For the prevention of nausea and vomiting induced by cytotoxic therapy and postoperative. View
TLFDB09216(Tolfenamic Acid) For the treatment of migraine. View
TLSDB00966(Telmisartan) Used alone or in combination with other classes of antihypertensives for the treatment of hypertension. Also used in the treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes mellitus, as well as the treatment of congestive heart failure (only in patients who cannot tolerate ACE inhibitors). View
TLTDB00500(Tolmetin) For the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis, including the treatment of acute flares long-term management. Also for treatment of juvenile rheumatoid arthritis. View
TMGDB00730(Thiabendazole) For the treatment of strongyloidiasis (threadworm), cutaneous larva migrans (creeping eruption), visceral larva migrans, and trichinosis. View
TMIDB04794(Bifonazole) Used for the treatment of various topical fungal infections, including athlete's foot (tinea pedis). View
TMQDB01157(Trimetrexate) For use, with concurrent leucovorin administration (leucovorin protection), as an alternative therapy for the treatment of moderate-to-severe <i>Pneumocystis carinii</i> pneumonia (PCP) in immunocompromised patients, including patients with the acquired immunodeficiency syndrome (AIDS). Also used to treat several types of cancer including colon cancer. View
TNGDB00727(Nitroglycerin) For the prevention of angina View
TOPDB00440(Trimethoprim) For the treatment of urinary tract infections, uncomplicated pyelonephritis (with sulfamethoxazole) and mild acute prostatitis. May be used as pericoital (with sulfamethoxazole) or continuous prophylaxis in females with recurrent cystitis. May be used as an alternative to treat asymptomatic bacteriuria during pregnancy (only before the last 6 weeks of pregnancy). Other uses include: alternative agent in respiratory tract infections (otitis, sinusitus, bronchitis and pneumonia), treatment of Pneumocystis jirovecii pneumonia (acute or prophylaxis), Nocardia infections, and traveller's diarrhea. View
TORDB00273(Topiramate) Used for the treatment and control of partial seizures and severe tonic-clonic (grand mal) seizures and also for the prevention of migraine headaches. In children it is also used for treatment of Lennox-Gastaut syndrome. Qsymia® is indicated for the treatment and management of obesity. View
TOYDB00684(Tobramycin) For the treatment of pseudomonas aeruginosa lung infections. Also being investigated for use in the treatment of sinus infections. View
TP0DB00321(Amitriptyline) - Indicated for the treatment of major depressive disorder in adults View
TPADB00752(Tranylcypromine) For the treatment of major depressive episode without melancholia. View
TPFDB00196(Fluconazole) For the treatment of fungal infections. View
TPVDB00932(Tipranavir) For combination antiretroviral treatment of HIV-1 infected adult patients with evidence of viral replication, who are highly treatment-experienced or have HIV-1 strains resistant to multiple protease inhibitors. View
TR6DB00685(Trovafloxacin) For treatment of infections caused by susceptible strains of the designated microorganisms in uncomplicated urethral gonorrhea in males and endocervical and rectal gonorrhea in females caused by <i>Neisseria gonorrhoeae</i> as well as non gonoccocal urethritis and cervicitis due to <i>Chlamydia trachomatis</i>. View
TRPDB00150(L-Tryptophan) Tryptophan may be useful in increasing serotonin production, promoting healthy sleep, managing depression by enhancing mental and emotional well-being, managing pain tolerance, and managing weight. View
TRUDB01021(Trichlormethiazide) Used in the treatment of oedema (including that associated with heart failure) and hypertension. View
TTCDB01030(Topotecan) For the treatment of advanced ovarian cancer in patients with disease that has recurred or progressed following therapy with platinum-based regimens. Also used as a second-line therapy for treatment-sensitive small cell lung cancer, as well as in combination with cisplatin for the treatment of stage IV-B, recurrent, or persistent cervical cancer not amenable to curative treatment with surgery and/or radiation therapy. View
TUBDB01199(Tubocurarine) Used as a diagnosis agent for myasthenia gravis, and also to facilitate the intubation after induction of anesthesia in surgical procedure View
TXCDB00577(Valaciclovir) For the treatment or suppression of cold sores (herpes labialis), herpes zoster (shingles), genital herpes in immunocompetent individuals, and recurrent genital herpes in HIV-infected individuals. View
TXLDB01248(Docetaxel) For the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Also used as a single agent in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. It is also used in combination with prednisone, in the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer. Furthermore, docetaxel has uses in the treatment of gastric adenocarinoma and head and neck cancer. View
TYLDB00316(Acetaminophen) For temporary relief of fever, minor aches, and pains. View
TZNDB01162(Terazosin) For the treatment of symptomatic BPH and mild to moderate hypertension. View
UEGDB00165(Pyridoxine) Pyridoxine is indicated for the treatment of vitamin B6 deficiency and for the prophylaxis of [DB00951]-induced peripheral neuropathy. It is also approved by Health Canada for the treatment of nausea and vomiting in pregnancy in a combination product with [DB00366] (as the commercially available product Diclectin). View
URFDB00544(Fluorouracil) For the topical treatment of multiple actinic or solar keratoses. In the 5% strength it is also useful in the treatment of superficial basal cell carcinomas when conventional methods are impractical, such as with multiple lesions or difficult treatment sites. Fluorouracil injection is indicated in the palliative management of some types of cancer, including colon, esophageal, gastric, rectum, breast, biliary tract, stomach, head and neck, cervical, pancreas, renal cell, and carcinoid. View
V2HDB06410(Doxercalciferol) Doxercalciferol is indicated for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis, as well as for the treatment of secondary hyperparathyroidism in patients with Stage 3 or Stage 4 chronic kidney disease. View
VD3DB00169(Cholecalciferol) For the treatment of vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or corticosteroid-induced osteoporosis. View
VDNDB00862(Vardenafil) Used for the treatment of erectile dysfunction View
VDXDB00136(Calcitriol) Used to treat vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or corticosteroid-induced osteoporosis. View
VDYDB00146(Calcidiol) Used to treat vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or corticosteroid-induced osteoporosis. View
VGHDB08865(Crizotinib) Crizotinib is used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic-lymphoma kinase (ALK)-positive as detected by a FDA-approved test. View
VIADB00203(Sildenafil) For the treatment of erectile dysfunction and to relieve symptoms of pulmonary arterial hypertension (PAH). View
VIBDB00152(Thiamine) For the treatment of thiamine and niacin deficiency states, Korsakov's alcoholic psychosis, Wernicke-Korsakov syndrome, delirium, and peripheral neuritis. View
VISDB08828(Vismodegib) Vismodegib is used for treating locally advanced or metastatic basal cell carcinoma in patients whose carcinoma has recurred after surgery, and in patients who are not candidates for surgery or radiation. View
VIVDB00163(Vitamin E) Vitamin E, known for its antioxidant activities, is protective against cardiovascular disease and some forms of cancer and has also demonstrated immune-enhancing effects. It may be of limited benefit in some with asthma and rheumatoid arthritis. It may be helpful in some neurological diseases including Alzheimer's, some eye disorders including cataracts, and diabetes and premenstrual syndrome. It may also help protect skin from ultraviolet irradiation although claims that it reverses skin aging, enhances male fertility and exercise performance are poorly supported. It may help relieve some muscle cramps. View
VK3DB00170(Menadione) The primary known function of vitamin K is to assist in the normal clotting of blood, but it may also play a role in normal bone calcification. View
VLBDB00570(Vinblastine) For treatment of breast cancer, testicular cancer, lymphomas, neuroblastoma, Hodgkin's and non-Hodgkin's lymphomas, mycosis fungoides, histiocytosis, and Kaposi's sarcoma. View
VOGDB04878(Voglibose) For the treatment of diabetes. It is specifically used for lowering post-prandial blood glucose levels thereby reducing the risk of macrovascular complications. View
VORDB00582(Voriconazole) For the treatment of esophageal candidiasis, invasive pulmonary aspergillosis, and serious fungal infections caused by <i>Scedosporium apiospermum</i> and <i>Fusarium</i> spp. View
VPXDB09030(Vorapaxar) Vorapaxar is indicated for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or peripheral arterial disease (PAD). It is usually co-administered with acetylsalicylic acid (ASA) and/or clopidogrel, and should therefore be administered as an addition to these medications as it has not been studied alone. View
W9TDB00581(Lactulose) For the treatment of constipation and hepatic encephalopathy. View
WJZDB06823(Tiopronin) Tiopronin is indicated for the prevention of kidney stone formation in patients with severe homozygous cystinuria consisting of a urinary cystine concentration greater than 500 mg/day, and who have failed treatment with non-pharmacological measures of increased fluid intake, decreased sodium and protein intake, and urine alkalinization. View
WPPDB00319(Piperacillin) For the treatment of polymicrobial infections. View
X0TDB00651(Dyphylline) For relief of acute bronchial asthma and for reversible bronchospasm associated with chronic bronchitis and emphysema. View
X2NDB01263(Posaconazole) For prophylaxis of invasive <em>Aspergillus</em> and <em>Candida</em> infections in patients, 13 years of age and older, who are at high risk of developing these infections due to being severely immunocompromised as a result of procedures such as hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD), or due to hematologic malignancies with prolonged neutropenia from chemotherapy. Also for the treatment of oropharyngeal candidiasis, including oropharyngeal candidiasis refractory to itraconazole and/or fluconazole. Posaconazole is used as an alternative treatment for invasive aspergillosis, <em>Fusarium</em> infections, and zygomycosis in patients who are intolerant of, or whose disease is refractory to, other antifungals. View
X6XDB01296(Glucosamine) Glucosamine is usually used in the treatment of osteoarthritis, although its efficacy is still in question. View
X89DB01110(Miconazole) For topical application in the treatment of tinea pedis (athlete&rsquo;s foot), tinea cruris, and tinea corporis caused by <i>Trichophyton rubrum</i>, <i>Trichophyton mentagrophytes</i>, and <i>Epidermophyton floccosum</i>, in the treatment of cutaneous candidiasis (moniliasis), and in the treatment of tinea versicolor. View
X8ZDB01197(Captopril) For the treatment of essential or renovascular hypertension (usually administered with other drugs, particularly thiazide diuretics). May be used to treat congestive heart failure in combination with other drugs (e.g. cardiac glycosides, diuretics, &beta;-adrenergic blockers). May improve survival in patients with left ventricular dysfunction following myocardial infarction. May be used to treat nephropathy, including diabetic nephropathy. View
XINDB09079(Nintedanib) Nintedanib is indicated for the treatment of idiopathic pulmonary fibrosis (IPF). View
XPGDB00770(Alprostadil) For palliative, not definitive, therapy to temporarily maintain the patency of the ductus arteriosus until corrective or palliative surgery can be performed in neonates who have congenital heart defects and who depend upon the patent ductus for survival. Also for the treatment of erectile dysfunction due to neurogenic, vasculogenic, psychogenic, or mixed etiology. View
XRADB00457(Prazosin) For treatment of hypertension, symptomatic benign prostatic hyperplasia, and severe congestive heart failure. May also be used alone or in combination with &beta;-blockers in the preoperative management of signs and symptoms of pheochromocytoma. View
Y00DB00841(Dobutamine) For inotropic support in the short- term treatment of patients with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures View
Y70DB08910(Pomalidomide) Pomalidomide is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy. View
YMZDB00358(Mefloquine) For the treatment of mild to moderate acute malaria caused by Mefloquineuine-susceptible strains of <i>Plasmodium falciparum</i> (both chloroquine-susceptible and resistant strains) or by <i>Plasmodium vivax</i>. Also for the prophylaxis of <i>Plasmodium falciparum</i> and <i>Plasmodium vivax</i> malaria infections, including prophylaxis of chloroquine-resistant strains of <i>Plasmodium falciparum</i>. View
YNUDB00700(Eplerenone) For improvement of survival of stable patients with left ventricular systolic dysfunction (ejection fraction <40%) and clinical evidence of congestive heart failure after an acute myocardial infarction. View
YTZDB06147(Sulfathiazole) Sulfathiazole is effective against a wide range of gram positive and gram negative pathogenic microorganisms. Although no longer used in humans, it is used in cattle. View
YY3DB09330(Osimertinib) Osimertinib is indicated for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA- approved test, who have progressed on or after EGFR-TKI therapy. View
Z80DB00477(Chlorpromazine) For the treatment of schizophrenia; to control nausea and vomiting; for relief of restlessness and apprehension before surgery; for acute intermittent porphyria; as an adjunct in the treatment of tetanus; to control the manifestations of the manic type of manic-depressive illness; for relief of intractable hiccups; for the treatment of severe behavioral problems in children (1 to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability, and poor frustration tolerance. View
ZD6DB05294(Vandetanib) Vandetanib is currently approved as an alternative to local therapies for both unresectable and disseminated disease. Because Vandetanib can prolong the Q-T interval, it is contraindicated for use in patients with serious cardiac complications such as congenital long QT syndrome and uncompensated heart failure. View
ZITDB00207(Azithromycin) For the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions: <i>H. influenzae</i>, <i>M. catarrhalis</i>, <i>S. pneumoniae</i>, <i>C. pneumoniae</i>, <i>M. pneumoniae</i>, <i>S. pyogenes</i>, <i>S. aureus</i>, <i>S. agal</i> View
ZK5DB00687(Fludrocortisone) For partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease and for the treatment of salt-losing adrenogenital syndrome. View
ZLDDB00601(Linezolid) For the treatment of bacterial infections caused by susceptible strains of vancomycin resistant <i>Enterococcus faecium</i>, <i>Staphylococcal aureus</i> (methicillin resistant and susceptible strains), <i>Streptococcus pneumoniae</i>, <i>Streptococcus pyogenes</i>, <i>Streptococcus agalactiae</i>. View
ZMRDB00558(Zanamivir) For the prevention and treatment of influenza A and B. View
ZOLDB00399(Zoledronic acid) For the treatment of hypercalcemia of malignancy. Also for the treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy. In May of 2007, the drug was approved for treatment of Paget’s Disease. View
ZONDB00909(Zonisamide) For use as adjunctive treatment of partial seizures in adults with epilepsy. View
ZOTDB09225(Zotepine) For the treatment of acute and chronic schizophrenia. View
ZPCDB00402(Eszopiclone);DB01198(Zopiclone) For the treatment of insomnia;For the short-term treatment of insomnia. View
T3DB00279(Liothyronine) Used as replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyrodism during the recovery phase of subacute thyroiditis. View